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Abstract 
 
In acute stroke, the effect of both acute treatments and secondary prevention is time-
dependent. Patients´ delay is an important obstacle to acute recanalization therapy 
for stroke. To decrease this delay, a stroke educational campaign was carried out in 
Sweden. After an ischemic event, the risk of early recurrent stroke is particularly 
high if the event is caused by a carotid stenosis. Urgent carotid endarterectomy 
(CEA) reduce the risk of recurrent stroke, but the optimal timing for CEA after a 
cerebrovascular event is not known because of uncertainties with respect to the 
procedural risk in very urgent CEA. The aim of this thesis was to investigate the 
effects of the stroke campaign, and to investigate the procedural risk of very urgent 
CEA.  
 
Study I, a study based on telephone interviews, evaluated public stroke knowledge 
and intent to call 112 before the stroke campaign. Seventy-two percent could report 
at least one stroke symptom and 65% indicated they would call 112 for stroke. 
 
Study II, a study based on telephone interviews, investigated the effect of the 
campaign on awareness of the AKUT (equivalent to the FAST, Face-Arm-Speech-
Time) test and intent to call 112. Before the campaign started, 15% had heard about 
the AKUT test, compared with 51% during and directly after the campaign, and 
50% 21 months later. Corresponding figures were 65%, 76% and 73% for intent to 
call 112. 
 
Study III, a prospective national study, evaluated the effect of the campaign on pre-
hospital delay and recanalization therapy rate. During the campaign, but not the year 
before, nor the year after, the proportion arriving at hospital within three hours from 
stroke onset and the proportion receiving recanalization therapy increased 
significantly.  
 
Study IV, a prospective controlled study, compared the procedural risk in patients 
undergoing CEA < 48 hours with CEA 2-14 days from an ischemic event. Patients 
undergoing CEA < 48 hours from symptom onset had a higher risk of complications 
(stroke and/or death) compared with those operated on later, 8.0% versus 2.9%. 
 
In conclusion, public awareness of stroke was rather low in Sweden and was 
increased by the Swedish National Stroke Campaign. The campaign was also 
associated with a sustained increase in the proportion receiving recanalization 
therapy and with a small improvement of the proportion arriving at hospital within 
three hours. CEA < 48 hours was associated with a higher procedural risk compared 
with surgery 2-14 days after an ischemic event.  
 
 
Keywords: stroke, transient ischemic attack, campaign, carotid artery stenosis. 
Populärvetenskaplig 
sammanfattning på svenska  
 
Stroke är ett samlingsnamn för hjärninfarkt (blodpropp) och hjärnblödning 
och är en vanlig orsak till både död och förvärvat funktionshinder. Ungefär 
85% av alla stroke är orsakade av en hjärninfarkt (ischemisk stroke) och 
beror på att en blodpropp täppt till en av hjärnans blodkärl. Vanliga symtom 
på stroke är hängande mungipa, svaghet i ena armen och/eller benet samt 
svårigheter att tala. Symtomen debuterar plötsligt. Transitorisk ischemisk 
attack (TIA) är en snabbt övergående syrebrist i ett område i hjärnan. 
Syrebristen orsakas av en blodpropp i ett blodkärl. Blodproppen löses upp av 
kroppens egna proppnedbrytande system efter en kort tid. Symtomen är 
samma som de som uppträder vid stroke, men går över inom några 
minuter/timmar.  
Vid stroke och TIA är behandling i tid avgörande för behandlingarnas 
effektivitet, både vad gäller möjliga akuta behandlingar som kan minska de 
skadliga effekterna av en stroke och behandlingar som syftar till att 
förebygga ett återinsjuknande i stroke. En stor andel patienter med stroke 
kommer dock för sent till sjukhus för att kunna få effektiv akutbehandling 
mot proppar i form av trombolys (propplösande dropp) och/eller 
trombektomi (mekaniskt avlägsnande av proppen). För att fler patienter med 
stroke skall komma till sjukhus utan onödig fördröjning genomförde 
Sveriges Landsting och Regioner en strokekampanj under 2011 till 2013 
med syftet att öka befolkningens kunskap om stroke. Målsättningen var att 
lära befolkningen känna igen de vanligast strokesymtomen och öka 
kunskapen om vikten av att omedelbart larma 112 genom att lära ut det så 
kallade AKUT-testet (A-ansikte, K-kroppsdel, U-uttal och T-tid). 
Hos patienter med TIA eller lindrig stroke är risken för att återinsjukna i 
stroke under den närmaste tiden efter det första insjuknandet hög. Särskilt 
hög är risken om den bakomliggande orsaken är en förträngning i 
halspulsådern (s.k. karotisstenos) vilket orsakas av åderförkalkning. 
Kirurgisk behandling av karotisstenos, i kombination med medicinering, 
minskar risken för återinsjuknande i stroke jämfört med enbart medicinsk 
behandling. En bättre effekt erhålls om operationen görs inom de två första 
veckorna än om operationen utförs senare i förloppet efterföljande en stroke 
eller TIA. Det är dock fortsatt oklart exakt när, under dessa två veckor, det är 
optimalt att opereras. Med hänsyn till den höga risken att återinsjukna i 
stroke redan under de första dygnen, borde så tidig operation som möjligt 
vara att föredra. Detta förutsätter dock att komplikationsrisken vid 
operationen inte är högre än vid en senare utförd operation. 
De två övergripande syftena med avhandlingsarbetet var (1) att undersöka 
effekterna av den nationella strokekampanjen med fokus på kunskap om 
stroke, ledtider från strokeinsjuknande till ankomst till sjukhus samt om fler 
fått tillgång till effektiv akutbehandling (trombolys och/eller trombektomi) 
och (2) att undersöka risken för komplikation med stroke och/eller död i 
samband med operation av karotisstenos som utförs inom 48 timmar efter 
symtomdebut jämfört med operation som utförs senare (48 timmar-14 dagar 
efter symtomdebut).  
Delarbete I: Innan den nationella strokekampanjen genomfördes 
konstaterades via telefonintervjuer att knappt 65% uppgav att de skulle ringa 
112 vid stroke. Endast 13% kunde uppger minst tre symtom på stroke medan 
46% kunde uppge minst tre riskfaktorer för stroke. Män och lågutbildade 
hade generellt lägre kunskap om stroke. Äldre uppgav i lägre utsträckning än 
yngre att de skulle ringa 112, trots att de inte hade sämre kunskap om 
riskfaktorer eller strokesymtom. 
Delarbete II: Telefonintervjuer visade att den nationella strokekampanjen har 
ökat befolkningens kunskap om stroke. Kunskapen ökade i alla grupper, 
oavsett kön, ålder och utbildningsnivå. Äldre människors kännedom om 
AKUT-testet och behovet att ringa 112 vid strokesymptom förbättrades dock 
i lägre utsträckning än medelålders och yngre personer. 
Delarbete III: I denna studie fann vi att andelen som erhöll akutbehandling 
mot proppar (trombolys och/eller trombektomi) vid ankomst till sjukhuset 
ökade från 10,3% året innan kampanjen till 13,3% under kampanjens sista 
tolv månader. Andelen strokepatienter som kom in till sjukhus inom tre 
timmar från insjuknande ökade från 36,3% året innan kampanjen till 37,4% 
under kampanjens sista tolv månader. Såväl året före som efter kampanjen 
skedde ingen ökning, vilket talar för att ökningen under kampanjen var en 
effekt av själva kampanjen. 
Delarbete IV: Vi observerade en ökad risk för stroke och/eller död inom 30 
dagar efter operation i gruppen som opererades inom 48 timmar jämfört med 
de som opererades 48 timmar-14 dagar efter symtomdebut (8,0% jämfört 
med 2,9%). 
Konklusion: Innan kampanjen hade befolkningen en relativt låg kunskap om 
stroke. Kampanjens effekt kunde tydligast läsas av i form av en ökad 
kunskap om stroke i befolkningen och andelen som erhöll akutbehandling 
med trombolys och/eller trombektomi. Endast en marginell ökning av 
andelen som kom till sjukhus inom tre timmar från insjuknandet 
observerades. Operation av symtomgivande karotisstenos inom 48 timmar 
efter stroke/TIA var förenad med en ökad komplikationsfrekvens varför den 
förväntade nyttan med tidig kirurgi fortsättningsvis måste vägas mot den 
ökade operationsrisken.  
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Abbreviations 
 
Afx Amaurosis fugax  
CEA Carotid endarterectomy 
CI Confidence interval 
CT Computer tomography 
cTIA Crescendo TIA 
ECST European Carotid Surgery Trial 
EVT Endovascular treatment 
FAST Face-Arm-Speech-Time 
HTA Health-technology assessment 
ICD International Classification of Diseases 
IVT Intravenous thrombolysis 
MRI Magnetic resonance imaging 
MRA Magnetic resonance angiography 
mRS Modified Rankin Scale  
NASCET North American Symptomatic Carotid Endarterectomy Trial 
NIHSS National Institutes of Health Stroke Scale 
OR Odds ratio 
PET Positron emission tomography 
P-value Level of significance 
RCT Randomized Controlled Trial 
RI Retinal infarction 
SALAR The Swedish Association of Local Authorities and Regions 
SAS Statistical Analysis Software 
SD Standard deviation 
SOS-alarm The service coordinating ambulance calls in Sweden 
SPSS Statistical Package for Social Sciences for Windows 
SW-RCT Stepped-Wedge cluster Randomized Controlled Trial 
TIA Transient Ischemic Attack 
tPA Tissue Plasminogen Activator 
WHO World Health Organization 
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Introduction 
 
Stroke  
Worldwide, stroke is one of the leading causes of death and disability. 
Globally, and in Sweden, stroke is the second most common cause of 
premature mortality after ischemic heart disease (1, 2). Although age-
standardized rates of stroke mortality have decreased worldwide in the past 
two decades, the absolute number of people who have a stroke every year, 
and live with the consequences, or die from their stroke, are increasing due to 
ageing and population growth. However, there are substantial geographical 
differences in both stroke burden and the directions of change by country 
income level, with a threefold increased burden due to stroke in low-income 
countries compared with high-income countries. In addition, there is a much 
greater reduction in stroke mortality rate in high-income countries than in 
low-income countries (3). Rising levels of obesity and diabetes (risk factors 
for stroke) in many countries make this an area of major concern for global 
health. Thus, stroke remains one of the principal global health challenges, and 
its significance is likely to increase.  
In Sweden about 25 000 people having a stroke every year (4, 5). This 
corresponds to one person having a stroke almost every twenty minutes. 
Stroke prevention and acute treatment that minimize the consequences of a 
developing stroke is therefore essential for the person at risk for having a 
disabling stroke as well as for the society.  
 
Definition of stroke and stroke subtypes 
The World Health Organization (WHO) defines stroke as “rapidly developing 
clinical signs of focal, and at times global, loss of cerebral function, with 
symptoms lasting more than 24 hours or leading to death, with no apparent 
cause other than vascular origin” (6).  
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Stroke is classified as ischemic or hemorrhagic based on the underlying 
pathology. For correct classification neuroimaging with either computer 
tomography (CT) or magnetic resonance imaging (MRI) is required. 
Hemorrhagic stroke arises when a blood vessel ruptures and causes an 
intracranial bleeding. The blood compresses and distorts the cerebral tissue, 
causing cell death. Hemorrhagic stroke can be either classified as 
intracerebral hemorrhage or subarachnoid hemorrhage based on the site of the 
bleeding. In ischemic stroke, a blood vessel becomes obstructed and this leads 
to a sudden lack of blood supply, causing focal cerebral ischemia and cell 
death. Stroke symptoms lasting less than 24 hours are called a transient 
ischemic attack (TIA). Worldwide, the incidence of ischemic stroke is twice 
as high as hemorrhagic stroke (7, 8), but in high-income countries such as 
Sweden, ischemic stroke constitutes about 85% of all strokes (9). According 
to a recent systematic review and meta-analysis (10), 22% of ischemic strokes 
are caused by an embolus from the heart, 23% by large artery atherosclerosis 
(such as carotid artery stenosis) and 22% by small artery occlusion. About 
26% of all ischemic strokes are classified as undetermined causes. In 3% of 
the cases, the cause is uncommon, such as dissection, or vasculitis. 
 
Risk factors for stroke and TIA 
There are several well-known risk factors for stroke and TIA. Age is an 
important, non-modifiable, risk factor. From different studies, including 
clinical trials, prospective cohort studies, and case-control studies (11-15), 
we know that hypertension, smoking, obesity, unhealthy diet, physical 
inactivity, diabetes, heavy alcohol intake, psychological stress and 
depression, hyperlipidemia and cardiac causes (for example atrial 
fibrillation) increase the risk of stroke. The recent INTERSTROKE study 
(15) estimated that these ten potentially modifiable risk factors accounted for 
approximately 90% of all strokes. Hypertension was more strongly 
associated with intracerebral hemorrhage than with ischemic stroke, whereas 
current smoking, diabetes, apolipoproteins and cardiac causes were more 
strongly associated with ischemic stroke. However, hypertension is the most 
important modifiable risk factor for both hemorrhagic and ischemic stroke. 
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Time is brain in acute stroke  
Understanding the mechanisms in acute stroke and why time is 
so important 
In 1977, Astrup et al (16, 17) showed that after the onset of focal ischemia in 
nonhuman primate brain, measurements of electrical activity revealed 
regions that were dysfunctional but not yet dead. In the central areas of the 
stroke lesion, blood flow deficits were severe and cells died rapidly. In the 
peripheral areas of the stroke, blood flow deficits were milder. When Astrup 
et al increased the blood pressure and improved collateral blood flow, these 
areas recovered. Astrup et al called this brain area the penumbra, named 
after the astronomical term indicating areas of half-light and half-shadow 
(Figure 1). The penumbra referred to the areas of the brain that were 
damaged but not yet dead, offering the promise that if proper therapies could 
be instituted in time it would be possible to rescue brain tissue following a 
stroke (Figure 2). Since this study, penumbral science became an active area 
that rapidly increased our knowledge about the underlying mechanisms in 
brain ischemia.  
A systematic review (18) of studies concerning brain ischemia has shown 
that for every minute delay in recanalization of a large supratentorial 
ischemic stroke an average of two million neurons are lost. Thus, avoiding 
delays to treatment will increase the number of patients with good clinical 
outcome. However, there is variability in the progression of penumbral 
regions to infarct core between individuals depending on the collateral 
circulation. The establishment of an infarct can take only a few minutes, but 
can also occur many hours later (19).  
In the 1990s, it was possible to visualize the penumbra in vivo using brain 
positron emission tomography (PET) scanning or MRI which allowed for the 
identification of acute stroke patients still having a penumbra and thus 
receptive for restorative treatments (20-22). Further evolvements of brain 
imaging have since then revolutionized the diagnostics of acute stroke.  
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Currently, even more advanced stroke CT and MRI perfusion protocols 
include detailed information about the relative sizes of the infarct core and 
the penumbra (infarct/penumbra mismatch). Beyond providing high-
resolution images of the anatomical localization and distribution of the brain 
infarct, such imaging techniques supply real-time dynamic information about 
the individual stroke pathophysiology (23). 
 
 
 
Figure 1. Penumbra, named after the astronomical term indicating areas of 
half-light and half-shadow. 
 
 
 
    Minutes                                        Hours                                      Days 
Figure 2. Illustration of the penumbra concept. The penumbra refers to the 
areas of the brain that are damaged but not yet dead. Orange = penumbra, 
red = manifest infarction. 
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Treatment in acute ischemic stroke 
Therapeutic approaches should reflect the logical application of our present 
understanding of the sequence of events in the ischemic brain leading to 
cerebral infarction. After understanding the concept of penumbra, there was 
reason to believe that early treatment with restoration of the blood supply 
might save the ischemic tissue and improve outcome.  
A milestone for stroke treatment was reached in 1996 in the USA (and 2002 
in Europe), when intravenous thrombolysis (IVT) was approved for 
treatment of acute ischemic stroke after having been proven to increase the 
proportion of patients with good functional outcome in randomized trials 
(24, 25). A meta-analysis (26) of nine randomized trials showed that 
treatment within three hours from stroke onset resulted in a good functional 
outcome, according to modified Rankin Scale, in 33%, compared to 23% in 
the placebo group (OR 1.75, 95% CI 1.35-2.27). Corresponding figures for 
patients treated 3-4.5 hours from stroke onset, were 35% for patients treated 
with IVT, compared to 30% in the placebo group (OR 1.26, 95% CI 1.05-
1.51). Irrespective of age and stroke severity, IVT significantly improves the 
odds of a good stroke outcome when given within 4.5 hours from stroke 
onset, with earlier treatment associated with proportionally larger benefits. 
Another milestone for stroke treatment was reached in 2015, when 
endovascular treatment (EVT) with mechanical thrombectomy in 
combination with IVT was shown superior to IVT alone when treating large 
vessel occlusions in the supratentorial anterior circulation. The combination 
of EVT and IVT almost doubled the chance of good functional outcome, 
compared with IVT alone (27-32) when performed within six hours from 
stroke onset. However, progression from amendable penumbra to manifest 
infarction varies substantially between individuals, mainly due to differences 
in collateral vessel status. The inclusion of perfusion techniques (CT or 
MRI) in the acute stroke management algorithm allows for the identification 
of individual patients with large infarct/penumbra mismatch, whom can be 
successfully treated with EVT outside the six hours therapeutic window after 
symptom onset (33-35).  
In acute ischemic stroke, time is brain as the time from stroke onset to 
revascularization of the occluded vessel is an important prognostic factor. 
Annika Nordanstig 
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Therefore, the therapeutic window for any recanalization therapy (IVT 
and/or EVT) is narrow. Recombinant tissue Plasminogen Activator (tPA) for 
IVT is beneficial within the first 4.5 hours after stroke onset. However, 
stroke patients treated within 90 minutes after onset of symptoms show the 
greatest improvement, with a number needed to treat for good functional 
outcome (defined as symptom-free or residual symptoms with no loss of 
activity) of three. If tPA is started 3-4.5 hours after stroke onset, the number 
needed to treat is 14 (26). Although the time window for EVT is wider than 
for IVT, a short time from stroke onset to revascularization is the most 
important prognostic factor for good functional outcome, which is why 
treatment should be instituted as soon as possible (27-32).  
The establishment of stroke care units has markedly improved the outcome 
for stroke patients (36). However, following the breakthrough in 1996 when 
the FDA first approved tPA for stroke treatment, rapid stroke diagnosis 
became crucial and this markedly altered the clinical management of acute 
stroke. Previously, clinicians often waited 12-24 hours before establishing a 
diagnosis of acute stroke. Thus, over a fairly short period of time, stroke has 
evolved into an emergent condition with effective acute treatment options. 
Although the proportion of patients with ischemic stroke treated with IVT 
and/or EVT has steadily increased over the last years, the treatment rate is 
still low. Only 14% of all patients registered with ischemic stroke in Sweden 
received recanalization therapy in 2016 (4). 
 
Treatment in acute hemorrhagic stroke 
Hemorrhagic stroke also remains a significant cause of morbidity and 
mortality. However, except for stroke unit care, the current therapeutic 
options in the acute setting remain limited. Still, early deterioration within 
the first few hours after stroke onset is common and can be counteracted by 
emergent medical treatment that under the right circumstances may have a 
positive impact on the outcome. For patients suffering a hemorrhagic stroke, 
blood pressure lowering and reversal of coagulopathy should be initiated as 
soon as possible. Rarely, acute neurosurgical intervention is indicated (for 
example in cases with cerebellar hematoma or large lobar intracerebral 
hemorrhages) (37).  
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Time is brain in secondary prevention after TIA and 
ischemic stroke 
Early risk for stroke after TIA or minor stroke  
In 2004, Coull et al (38) showed that the early risk of stroke after a TIA or a 
minor stroke was much higher than commonly quoted at that time. The 
estimated risk for stroke after a TIA was 8.0% at seven days, 11.5% at one 
month, and 17.3% at three months. Corresponding figures for recurrent 
stroke after a minor stroke were 11.5%, 15.0% and 18.5%. The risk of early 
recurrent stroke is highest in patients with large-artery atherosclerosis (such 
as carotid stenosis) compared to other subtypes (odds ratio = 3.3, 95% CI = 
1.5-7.0) (39). When these studies were performed, it was unclear whether the 
risk could be reduced by more rapid instigation of preventive treatment (38, 
39).  
 
Secondary prevention after TIA or minor stroke  
Secondary prevention starts with deciphering the most likely mechanism for 
the ischemic stroke or TIA. One of the main goals in stroke prevention is to 
treat vascular risk factors such as hypertension, diabetes and dyslipidemia. 
Patients should be advised to stop smoking. Changes in lifestyle such as a 
healthy diet, exercise and avoiding obesity should be recommended. In case 
of cardioembolism, most often due to atrial fibrillation, anticoagulation is the 
mainstay of therapy. In other common etiologies, including large artery 
atherosclerosis, the best medical therapy consists of antiplatelets, statins, 
aggressive controls of vascular risk factors, and lifestyle modifications. In 
patients with a symptomatic carotid stenosis, carotid endarterectomy (CEA) 
is highly beneficial in addition to best medical treatment (40, 41). 
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The effects of rapid instigation of secondary prevention 
In 2004, a meta-analysis (42) showed that CEA for patients with 
symptomatic carotid stenosis was more favorable when done within the first 
two weeks after the ischemic event compared to later surgical intervention. 
However, these studies were not designed to determine whether surgery 
performed in the very early phase was even more beneficial. 
Consequently, in 2007, the Early use of EXisting PREventive Strategies for 
Stroke study (EXPRESS study) (43) was instigated to determine the effect of 
very early treatment after TIA and minor stroke. Briefly, the EXPRESS 
study compared two different modalities of management of patients with 
TIA or minor stroke in a population-based prospective before versus after 
cohort study. Patients referred to a specialized clinic between April 2002 and 
September 2004 (phase one) were compared with those referred between the 
period of October 2004 and March 2007 (phase two). During phase two, 
patients received a more urgent assessment and immediate initiation of 
treatment. In both phases, similar treatment protocols for stroke prevention 
were used (including antiplatelet, antihypertensive, anticoagulation and 
statin therapy, as well as carotid endarterectomy when indicated), the 
important difference being time elapsed between symptom onset, clinic 
assessment and initiation of treatment. The primary outcome was recurrent 
stroke within 90 days of presentation. The study showed that urgent 
assessment and treatment reduced the 90-day risk of recurrent stroke by 80% 
(10.3% vs 2.1%). Although the effect of the different treatment modalities 
could not be separated from each other, it was unlikely that CEA contributed 
significantly to the reduced stroke rate due to the relatively low number of 
surgical interventions. Thus, this study did not add evidence to the efficiency 
of very early carotid endarterectomy. 
Therefore, in addition to the narrow therapeutic window for recanalization 
therapy, it is important that patients seek medical care immediately to 
receive a more rapid initiation of secondary preventive treatment and thereby 
reduce the risk of recurrent stroke. However, although CEA should be done 
within 14 days, it is still not settled whether surgery within the first days is 
more beneficial.  
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Reasons for delay in acute stroke 
Omitting to activate emergency services is the single most important 
determinant causing delay in assessment for acute stroke (44, 45). The 
inability of people to recognize stroke symptoms and act optimally in case of 
stroke explains why people delay seeking urgent care for stroke (45-47).  
In 2009, a review (48) showed that the 50th percentile of the median pre-
hospital delays occurred between three and four hours and the proportion 
arriving at hospital within three hours ranged from 6% to 92%. Inclusion 
criteria varied across the studies, some focusing on patients with 
hemorrhagic or ischemic stroke or both, and some on patients with stroke-
like symptoms or with TIA. Therefore it is difficult to compare the results 
from these different studies. However, there was a decreasing trend over 
time in pre-hospital delay time, and studies including patients with stroke-
like symptoms seemed to have a lower proportion of patients arriving within 
three hours.  
 
Public stroke knowledge 
Public knowledge about stroke symptoms, appropriate action to take if 
stroke is suspected and ability to name risk factors for stroke varies 
markedly between studies (49). Reasons for these observed differences can 
be attributed to overall knowledge variations between populations. However, 
the results are also strongly related to how the questions are formulated and 
how provided answers are interpreted. It is therefore difficult to directly 
compare the reported results from these studies. Generally, when fixed 
options are provided (i.e. closed questions), studies tend to indicate better 
knowledge than when open-ended questions are used (49). For example, the 
ability to name one risk factor for stroke varies from 18% to 94% between 
studies when using open-ended questions and from 42% to 97% when closed 
questions are used. Corresponding figures regarding the ability to name one 
correct stroke symptom were 25% to 72% when asked open-ended questions 
and 95% to 100% when asked closed questions. The interpretation of a given 
answer can also differ substantially between studies, as the predetermined 
options considered correct differs. For example, if “weakness” is recorded as 
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a correct stroke symptom, the respondents´ knowledge of weakness as a 
stroke symptom may be overestimated compared to studies that only accept 
“unilateral weakness” as a correct answer. When asked what action people 
would take if stroke is suspected, between 53% and 98% replied that they 
would call the emergency medical services (49). In the majority of studies, 
older persons, ethnic minority groups, those with lower levels of education 
and men consistently had poorer levels of stroke knowledge (49-54). 
 
Stroke educational campaigns 
Given the importance of early activation of emergency services in acute 
stroke as described above, it is of paramount importance to increase the 
proportion of individuals who take appropriate actions when experiencing or 
witnessing stroke symptoms. In order to potentially reach this goal, stroke 
educational campaigns have been suggested.  
During the last decade, several mass-media campaigns targeting the general 
public and aiming at shortening pre-hospital delay have been conducted. In 
general, details of campaign design and practical execution is usually very 
briefly described. The degree of heterogeneity between different campaigns 
in terms of specific target population, duration of the intervention, main 
topics and messages, used media and costs, complicates comparisons 
between the various studies. In English-speaking countries, the FAST (Face, 
Arm, Speech, and Time) acronym is generally used as a mnemonic to help 
detect and enhance responsiveness to the needs of a person having a stroke.  
The majority of the campaigns carried through have been small and local, 
while only a few were implemented on a national level. Examples of 
national campaigns directed towards the public are a campaign performed in 
the Czech Republic in 2006-2009 and repeated campaigns in England, 
Ireland and Australia. 
The campaign conducted in the Czech Republic during 2006-2009 was 
based on donated advertising in media (radio, television, newspaper, posters, 
and websites) and the total cost for this campaign was estimated at 25,000 
EUR per year. 
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In 2009, the Department of Health in England launched a national stroke 
campaign that has been running in cycles since then (usually one or two 
campaign periods per year, each running during of one to two month). It 
includes television, press, and radio advertisements. The overall cost of the 
campaign is unclear, but not insignificant. For example, the Department of 
Health stated that the more restricted three month advertising campaign in 
2011 had a cost of about £740,000. In Ireland, the Irish Heart Foundation 
launched a similar national stroke awareness campaign in 2010 in order to 
communicate the importance of recognizing stroke symptoms and the 
significance of acting fast to get emergency help. As in England, the 
campaign has thereafter been repeated at regular intervals. In Australia, the 
National Stroke Foundation has run public stroke campaigns every year 
since 2004. In most years, the campaign period lasted for six weeks.  
 
Evaluation of stroke campaigns  
In the stroke campaign literature there are, in principal, two different main 
purposes when initiating a campaign. First, it may be conducted to increase 
stroke knowledge in the target population. Researchers following up the 
campaign have no influence on the campaign design itself. Secondly, a 
campaign may be started by a research group to test a hypothesis, e.g. if 
campaigns are effective or which campaign design is the most efficient. In 
these studies the main purpose for the campaign is to evaluate the effect of 
the campaign and not primarily to increase the stroke knowledge in the 
target population.  
 
There are different ways to evaluate the effect of a stroke educational 
campaign regarding outcomes. One is to assess if the campaign increases 
stroke knowledge and intent to call emergency services. Another is to review 
actual change in behavior, such as enhanced ambulance usage, shorter time 
from stroke onset to emergency services contact or reduced time from stroke 
onset to hospital admission. Yet another path is to measure the consequences 
of changed behavior, such as the proportion of stroke patients receiving 
recanalization therapy (55).  
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Media companies, on the other hand, commonly evaluate a campaign impact 
by measuring the proportion of individuals within the target population who 
are reached by the message in different media. From a scientific as well as a 
medical perspective, such indirect surrogate variables are less valuable due 
to uncertainty about campaign effects in terms of more patient-oriented 
endpoints.  
 
Stroke knowledge and intent to call 112 
In 2014, twenty-two intervention studies and five web-based educational 
stroke campaigns were included in a review (56). Of the intervention studies, 
all (22/22) included messages about stroke symptoms and 18/22 also 
included messages about the need to urgently call emergency services. All 
but one study reported positive results in at least one item (knowledge about 
stroke symptoms and/or intent to call emergency services). However, in 
several studies only women improved (57-59). The only negative study (60) 
concerned a national campaign conducted in the Czech Republic 2006-2009. 
Only 19% had noticed the campaign. Interestingly, respondents who noticed 
the campaign had better knowledge than respondents who did not. This was 
a campaign with an extremely low budget, which may affect the ability to 
reach the target population. Eight of the studies in the review had a control 
population. None of these were national campaigns. All 22 studies were 
before and after studies, but 16 studies collected post-intervention data at 
only one time-point. The other six studies followed up the campaign 
effectiveness through a time interval ranging from two to six months. One 
study (61) collected data after a five month advertising blackout, and found 
that knowledge declined post-intervention.  
Television proved to be the medium that yielded the most positive effects 
(56, 62), as it reaches many people and can be repeated several times per day 
for extended periods of time. Web-based campaigns are efficient in reaching 
a large number of people but tend to attract a selected population.  
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Patient behavior (patient delay, ambulance use and emergency 
department presentation) and consequences of behavior 
(recanalization therapy) 
In 2015, fifteen studies were included in a systematic review (55); one 
randomized controlled trial (RCT), two time series analyses, eight before 
and after studies (three included a control group not exposed to the 
campaign), two retrospective observational studies, and two prospective 
observational studies. Thirteen studies examined pre-hospital delay, eight 
studies examined thrombolysis rates, five studies examined ambulance use 
and three studies examined emergency department presentations.  
Ten studies (10/13) reported a significant reduction in pre-hospital delay 
times. Only three out of eight studies (3/8) showed a significantly increased 
proportion of patients treated with thrombolysis. Four out of five (4/5) 
studies reported a significant increase in the proportion of patients who 
arrived by ambulance. All studies (3/3) examining emergency department 
presentations reported some statistically significant effects, with increases in 
the number of emergency department presentations for stroke.  
Data on long-term effects are scarce in most studies. However, studies 
examining emergency department presentations, pre-hospital delay and/or 
thrombolysis rates found that the effect declined almost immediately after 
the campaign (63-66), suggesting that campaigns must be repeated regularly. 
 
How to measure the proportion reached by different media 
To purchase advertisement space can be very expensive, especially 
television advertisement. Advertisements running during evenings are more 
expensive compared to daytime advertisement because more people watch 
television in the evenings. The more reached, the more expensive. Reach is 
therefore an important measure for all kinds of advertisements as it reflects 
the proportion in the target group that is possible to reach with different 
media, for example with television or printed media.  
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However, reach refers to the total number of different people exposed to a 
medium during a given period. Reach should not be confused with the 
number of people who actually consume the advertisement. It is simply the 
number of people who are exposed to the medium. 
In Sweden, the proportion reached by television is measured by the People 
Meter using 1200 households representing a cross-section of households. A 
People Meter is an audience measurement tool used to measure the viewing 
habits of television audiences. The box is hooked up to the television set and 
has a remote control unit. Each family member in a sample household is 
assigned a personal “viewing button”.  
To measure the reach of printed media in Sweden, a professional media 
company (Sifo, the Swedish Institute for Opinion Surveys) commission 
repeated large market investigations using telephone interviews (three times 
each year). For both television and printed media, gross contacts in the target 
group can be measured. From this data the proportion reached by television 
and printed media, for example, at least once, at least twice and at least three 
times can be counted.  
Number of visitors is a commonly used evaluation tool to assess the impact 
of digital media advertisements and estimate data traffic. Both the total 
number of visitors as well as the number of unique visitors is measured. To 
measure the numbers of unique visitors, cookies are used. A cookie is a 
small piece of data sent from a website and stored on the user's computer. 
When you visit a site, it identifies if you have the cookie. If you have this 
cookie, you count as a recurring visitor, otherwise a new cookie will be 
added and you will count as a new unique visitor. However, cookies can be 
deleted and more than one person can use the same computer, which is why 
it´s important to note that a unique visitor is not a physical single person, but 
rather an estimate of data traffic. 
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The Swedish National Stroke Campaign 
The Swedish Association of Local Authorities and Regions (SALAR; an 
organization representing all Sweden´s municipalities, county councils and 
regions) developed and implemented the Swedish National Stroke 
Campaign. The main aim was to increase stroke knowledge and reduce delay 
to hospital arrival. The campaign ran between the 7th of October 2011 and 
the 31st of December 2013. The target audience was men and women aged 
15-79 years. To sustain the gains achieved, SALAR conducted a less 
comprehensive follow-up campaign the year following the campaign. 
The campaign used the mnemonic AKUT (a translation of the FAST 
acronym, where F stands for face drooping, A for arm weakness, S for 
slurred speech, and T for time to call 911) to develop the materials for the 
campaign (Figure 3). AKUT is also the Swedish word for acute. 
 
 
Figure 3. Example of the advertisement. 
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In the first part of the campaign, the advertisements described the simple 
three step AKUT test and the meaning of each letter of the acronym. The 
latter part of the campaign focused on consolidation of stroke knowledge by, 
for example, depicting a person experiencing a stroke. Such advertisements 
also contained the AKUT message but the actual test was not described in 
detail and the significance of the letters was not explained. 
The campaign included paid television advertisements, television spots that 
run on public service television, paid advertisements and banners in 
newspapers and social media. In addition, placards, cards, brochures and 
other printed materials were distributed at hospitals, outpatient clinics, 
worksites, sports clubs, sport events, pharmacies and health fairs. The stroke 
campaign also had a website (www.strokekampanjen.se) during the entire 
campaign and a Facebook page during the latter part. The website included 
information about stroke, available in fourteen different languages.  
The first month of the campaign was the most cost-intensive phase. In this 
phase the campaign was directed to the general public. In 2012 and 2013 the 
campaign was less intensive than in 2011 in terms of advertising aimed for 
the general public. During 2012 and the first half of 2013 the campaign was 
primarily focused on workplaces and sport clubs rather than the general 
public. Activities mainly included targeted advertising in the trade press, and 
a less intensive advertising on television, in newspapers and via banners 
aimed at the general public. Printed materials were sent to over 4000 
companies, communities, authorities and organizations with the purpose of 
activating the organization to reinforce the campaign message. Famous 
athletes participated in advertisements, and targeted advertising during major 
sports event also occurred. During the last year of the campaign social 
media, i.e. Facebook was used more often to promote the campaign message.  
Throughout the campaign period, the professional media company that 
designed the campaign performed repeated market investigations. These 
investigations identified men and younger people as groups with lower 
knowledge about the AKUT test and the need to call 112.  
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Accordingly, during the last part (second half of 2013) of the campaign the 
focus was shifted towards these target groups. To achieve this, the campaign 
advertisements were concentrated in conjunction with TV-programs 
primarily aimed for this specific audience. The most intensive phases in the 
campaign were in October-November every year. 
The Swedish county councils and regions, a part of SALAR, invested 50 
million SEK, around 5.5 million EUR (2011), in the main campaign. The 
year following the campaign (2014), the Swedish county councils and 
regions conducted a less comprehensive, mainly web-based, follow-up 
campaign with an additional budget of 3.5 million SEK, around 0.4 million 
EUR (2014).  
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Timely secondary prevention in symptomatic carotid 
stenosis  
As described above, the risk of early recurrent stroke is highest in TIA- and 
stroke patients with large artery atherosclerosis, such as carotid stenosis (39), 
compared to other etiological subtypes. A number of studies have reported a 
remarkably high risk of early stroke recurrence in patients with a TIA or 
minor stroke due to a > 50% carotid stenosis (NASCET criteria) (67-69). A 
review from 2015 estimated the stroke risk to 6.4% within the first two to 
three days, 19.5% at seven days and 26.1% at 14 days (70).  
Carotid endarterectomy (CEA) (Figure 4), in combination with best medical 
therapy, is the recommended treatment for stroke prevention in patients with 
symptomatic stenosis of the internal carotid artery (41).  
 
Background 
Large-artery atherosclerosis, a disease in large and medium sized pre-
cerebral and cerebral arteries, is considered to cause approximately 20% of 
all ischemic strokes. The atherosclerosis involves the parts of the arterial 
vessel wall that are closest to the lumen, the intima and media. 
Atherosclerosis leads to a thickening of the vessel wall resulting in formation 
of an atheroma (plaque) that narrows the lumen. The atheroma consists of 
lipids, inflammatory cells, and often calcifications. The atheroma has a lipid-
filled core, and a protected layer of smooth-muscle cells (fibrous cap) that 
reduce the risk of rupture (71). However, if the fibrous cap ruptures, the lipid 
core gets in contact with the bloodstream which leads to platelet activation 
and thrombosis formation that may embolize to the brain or retina. 
Atherosclerosis tends to appear particularly where there is branching, 
tortuosity or confluence of vessels, caused by turbulence in the blood flow. 
However, the proportion varies by sex, age and ethnicity (72, 73). In white 
populations, the atherosclerotic plaques are more frequent in the extracranial 
arteries whereas intracranial atherosclerosis is more prevalent among the 
Hispanic, Asian, and black populations. In a study performed in the United 
States (74), 16.6% of all ischemic strokes were caused by large-artery 
atherosclerosis. Of these, 8.0% had an extracranial carotid stenosis, 3.5% an  
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Figure 4. Carotid stenosis with an intra-plaque hemorrhage. Conventional 
carotid endarterectomy may be performed under local or general anesthesia. 
Neuromonitoring (carotid artery stump pressure or near-infrared 
spectroscopy) is commonly used under general anesthesia. In short, 
following dissection of the carotid artery bifurcation and systemic 
heparinization, the common and external carotid arteries are cross-clamped. 
If indicated by neuromonitoring, a shunt may be inserted to secure 
hemispheric perfusion. In the absence of shunt requirement, the internal 
carotid artery is subsequently cross-clamped. A longitudinal incision is made 
from the distal part of the common carotid artery, through the stenosis and 
up in to the internal carotid artery until a healthy and widely patent internal 
carotid artery segment is reached. The endarterectomy is thereafter carried 
out, removing the stenosing plaque by circumferential dissection within the 
natural cleavage plane located in the outer media vessel wall layer. The 
artery is thereafter closed, either by primary closure or by patch angioplasty 
depending on vessel diameter. Flow is restarted in the external- followed by 
the internal carotid artery. Photograph Klas Österberg. 
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extracranial carotid occlusion, and 3.5% had an intracranial atherosclerosis. 
The most common cause for associated cerebral ischemia is distal artery to 
artery embolization from the atherosclerotic lesion. Hemodynamic crisis due 
to the stenosis per se is less common. However, the most important clinical 
aspect of carotid stenosis is whether the stenosis is symptomatic or 
asymptomatic because the risk of stroke is much higher for patients with 
symptomatic stenosis. A carotid stenosis is classified as symptomatic if the 
patient has had symptoms compatible with vascular event in the anterior 
ipsilateral circulation.  
 
History of carotid endarterectomy and the effects of early 
surgery in patients with symptomatic carotid stenosis 
In 1975, DeBakey (75) published a case report about the first successful 
CEA for cerebrovascular insufficiency caused by atherosclerotic occlusion 
in the carotid artery. The surgery was performed in 1953 and the patient died 
from coronary occlusion 19 years after the carotid surgery.  
From the middle of 1970s and the subsequent two decades the numbers of 
carotid endarterectomies to prevent stroke increased. In 1976, 34 000 carotid 
endarterectomies were performed in the United States (76). With the 
increased numbers of carotid surgery, more complications with strokes were 
observed (77). To find out if carotid surgery did more harm than good, two 
landmark RCTs were performed (78-80). Both studies, The North American 
Symptomatic Carotid Endarterectomy Trial (NASCET) (78) and The 
European Carotid Surgery Trial (ECST) (79), concluded that carotid 
endarterectomy is of proven value in stroke prevention in selected 
symptomatic patients with carotid stenosis. Surgery was of marginal benefit 
in those with 50–69% (NASCET-criteria) stenosis (absolute risk reduction of 
4.6%, p = 0.04), and was highly beneficial in those with 70-99% stenosis 
(absolute risk reduction of 16.0%, p < 0.001) (81). Surgery was harmful in 
patients with a stenosis < 30%, and of no benefit in those with 30-49% 
stenosis. In both trials, the risk of stroke and/or death within 30 days of CEA 
was about 7% and did not differ between different stenosis groups.  
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In both trials, catheter angiography was used to define the degree of carotid 
stenosis and the results were expressed as a percentage reduction in vessel 
diameter. However, stenosis was measured differently in the two trials 
(Figure 5). Approximately, a 70% stenosis by the ECST method is 
equivalent to a 50% stenosis by the NASCET method, and an 80% stenosis 
by the ECST method is equivalent to a 70% stenosis by the NASCET 
method (82).  
 
 
 
Figure 5. Two different methods for calculating degree of stenosis.  
 
The diagnostic algorithm prior to carotid surgery has changed over the past 
years. Today most patients are investigated with non-invasive imaging 
(duplex ultrasound, magnetic resonance angiography (MRA), and/or CT 
angiography). Several studies showed that non-invasive methods are 
equivalent to angiography to investigate the degree of stenosis (83).  
In 2004, a meta-analysis (42) of these two large interventional studies of 
symptomatic carotid stenosis showed that surgery is more favorable when 
done within the first two weeks after the ischemic event as compared to later 
surgical intervention. This result was expected as the risk of recurrent stroke 
in patients with symptomatic carotid stenosis is highest in the first weeks 
after a TIA or minor stroke. Neither NASCET, nor ECST, were designed to 
determine whether surgery performed in the very early phase was even more 
beneficial. 
NASCET = 
ECST = 
A – B 
A 
C – B 
C
x 100 
x 100 
A
B 
C 
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Benefit of CEA in different subgroups 
The relative patient benefit from CEA not only depends on the degree of 
carotid artery stenosis and timing of CEA. Both the risk for an ipsilateral 
ischemic event following a TIA or minor stroke among patients with 
symptomatic carotid artery stenosis, and the risk for a complication (stroke 
and/or death) following CEA seems to be increased in patients presenting 
with hemispheric events (as compared to those with retinal events), in 
diabetic patients and in patients with irregular or ulcerated plaques (42). The 
perioperative risk of stroke and/or death is also higher in patients with 
contralateral internal carotid artery occlusion. The risk for an ischemic event 
following a TIA or minor stroke among patients with symptomatic carotid 
artery stenosis is higher in elderly people (> 75 years) explaining the greater 
benefit from CEA in this group (42). 
Finally, in both the NASCET and the ECST trials, the rate of ipsilateral 
stroke in the control group was significantly higher in men, but the rate of 
perioperative stroke (in the interventional group) was higher in women. 
Consequently, it was concluded that benefit from surgery was greater in 
men. However, more recent data suggests that, contrary to these previous 
reports, women do not have a higher risk of adverse events after CEA (84, 
85). 
 
Has the benefit of CEA changed over time? 
The net clinical benefit of CEA may change if the risk for an ischemic event 
following a TIA or minor stroke among patients with symptomatic carotid 
artery stenosis changes, and/or if the periprocedural risk change.  
The medical treatment has evolved during the last decades. In studies from 
the 1990s, aspirin was the antithrombotic drug of choice and a majority of 
the patients were not treated with statins. Urgently instituted and more 
aggressive pharmacotherapy (aspirin, clopidogrel and statins) may reduce 
the early risk of recurrent stroke in patients with a symptomatic significant 
carotid stenosis (86). 
Timely treatment in stroke and TIA 
 
 
35 
In both the NASCET and the ECST, the major complication rate was about 
7%. By contrast, only 3.6% of the patients who underwent CEA during the 
period from 2008 to 2015 in Sweden suffered a periprocedural complication 
(defined as any stroke and/or death within 30 days after the intervention). 
Furthermore, in the cohort that underwent carotid artery surgery for 
symptomatic carotid artery stenosis between 2014 and 2015, a significant 
lower major complication rate was also observed than in the corresponding 
patient cohort that underwent CEA 2008-2009 (87).  
Thus, patient benefit from CEA may have substantially evolved over time 
and this remains an intriguing and complex issue. 
 
Timing of carotid endarterectomy  
The optimal timing for CEA after TIA or minor stroke remains an important 
and controversial issue. The risk of recurrent stroke should be balanced to 
the risk of per- and postoperative complications. Most guidelines, including 
the Swedish guidelines (37), recommend surgery within 14 days of symptom 
onset (88).  
In the light of the high early risk for a recurrent disabling event, it is 
plausible to think that CEA performed in the very early period following an 
ischemic event could improve the benefit of CEA, if the risk of per- and 
postoperative complications risk remains similar, or only slightly increased, 
compared to later surgery. Potentially, the carotid plaques are more 
vulnerable immediately after an event and thus very urgent CEA may be 
accompanied by an increased risk for complications (89). There are no 
randomized studies comparing very early CEA (within 48 hours) with CEA 
2-14 days after symptom onset.  
In a health technology assessment (HTA) project (90) conducted at our 
hospital in 2009, five observational studies (91-95) reporting results of acute 
CEA within 48 hours after symptom onset compared with later surgery were 
identified. None of the studies showed significant differences in 
perioperative complications between the two surgery groups. However, the 
studies were relatively small and hampered by low external and internal 
validity. The years after the HTA project, several observational studies 
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reported on the stroke and mortality risk associated to CEA in the very early 
period after carotid related ischemic symptoms (96-105). In one register 
study (101), it was noted that patients operated within the first two days had 
an increased perioperative mortality and stroke risk (11.4% within two days 
versus 3.6% between three and seven days). However, other studies found 
no such differences (104, 105). A recent systematic review and meta-
analysis on early carotid intervention (106) conclude that the current 
evidence for very early CEA is limited, and that randomized controlled trials 
or prospective observational studies directly comparing acute CEA with 
subacute surgery are needed to elucidate the optimal timing of the 
intervention. 
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Aims 
 
The overall aim with this thesis is to generate knowledge that can improve 
timely acute treatment and secondary prevention in patients with acute 
cerebrovascular events. The specific aims were: 
Study I: To investigate public stroke awareness in Sweden. 
Study II: To study the impact of the Swedish National Stroke Campaign in 
terms of community awareness of the AKUT test (the campaign used the 
AKUT mnemonic: A for face drooping, K for arm/leg weakness, U for 
slurred speech, and T for time to call the emergency number 112) and the 
need to call 112.  
Study III: To study the effect of the Swedish National Stroke Campaign in 
terms of behavior and consequences measured as delay time prior to hospital 
admission, and the proportion of ischemic stroke patients (< 80 years) 
receiving early recanalization therapy.  
Study IV: To test the hypothesis that very early (within 48 hours) CEA in 
patients with symptomatic carotid stenosis would not increase the risk of 
per- or postoperative complications compared to CEA performed during the 
later period (48 hours to 14 days) after an ipsilateral cerebrovascular event. 
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Subjects and Methods 
 
Study Design 
The study design of the four studies is summarized in Table 1. There are two 
studies based on telephone interviews, one register based study and one 
prospective controlled study. 
Table 1. Overview of studies included in the thesis. CEA = Carotid 
endarterectomy. The AKUT test is a translation of the FAST acronym (F -
face drooping, A - arm weakness, S - for slurred speech, and T- time). 
Study Design  Participants Source Aims 
I Descriptive 
study, based 
on telephone 
interviews 
Randomly 
selected from 
the national 
phone number 
register,  
n =1500 
A national 
phone 
number 
register 
Evaluate public 
knowledge of stroke 
symptoms, risk factors 
and intent to call 112 for 
stroke symptoms 
II Before, 
during and 
after study, 
based on 
telephone 
interviews 
Randomly 
selected from 
the national 
phone number 
register, 
 n =11 913 
A national 
phone 
number 
register 
Evaluate the effect of the 
national campaign on 
public awareness of the 
AKUT test and the need 
to call 112  
III Prospective 
national 
cohort study, 
a register 
study 
Patients 
registered in 
Riksstroke 
2010-2014,  
n=97 840 
Riksstroke, 
Statistics 
Sweden 
Evaluate the effect of the 
national campaign on the 
proportion arriving at 
hospital <3 h from stroke 
onset and the proportion 
receiving recanalization 
therapy 
IV Prospective 
controlled 
study 
Patients with 
symptomatic 
carotid 
stenosis, 
n=418 
Consecutive 
regional 
hospital data 
Compare the procedural 
risk of CEA performed 
<48 h vs CEA 48 h-14 d 
following an ischemic 
event.  
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Subjects 
 
Study I and II  
The potential participants were randomly selected from a national phone 
number register of representative population samples of adults aged 18 to 79 
years from all of Sweden. The register includes fixed telephone networks, 
mobile phones and internet protocol telephony. About 75-80% of the 
Swedish population of age 18-79 years is registered in the register.  
 
Study III   
Patients presenting with acute stroke between October 1, 2010, and 
December 31, 2014, and who were recorded in the Swedish national quality 
register for stroke care (Riksstroke), were included in the study. Patients 
already enrolled at the hospital at the stroke onset were excluded.  
 
Study IV   
The two centers that perform CEA in the Region Västra Götaland in the 
South West of Sweden participated. Recruitment of consecutive consenting 
patients started at the Sahlgrenska University Hospital in October 2010 and 
at the second center Södra Älvsborg Hospital in June 2012. Recruitment 
continued until December 2015.  
Patients with symptoms compatible with a thromboembolic event in the 
anterior circulation, an ipsilateral carotid stenosis of 50-99% (NASCET 
criteria), and carotid surgery within 14 days after an ischemic event were 
eligible for the study. Except for the contraindications used in clinical praxis 
for CEA within 14 days (such as major stroke and patients with severe life-
limiting disease), patients treated with intravenous thrombolysis due to the 
ischemic event were excluded.  
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Methods 
 
Study I-II, based on telephone interviews 
A professional telephone interviewing company (www.indikator.org) was 
commissioned by the SALAR to conduct a random digit dial telephone 
survey by interviewing 1500 residents before, three times during, directly 
after and nine, 13 and 21 months after the campaign (i.e. at eight different 
time-points), see Figure 6. At least six attempts were made to complete 
unanswered calls. Call attempts were done at different days of the week and 
at different times of the day. When connecting, the interviewers asked for 
the holder of the dialed telephone number. Number of completed interviews, 
dropouts and reasons for dropouts were registered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Timing of the telephone surveys. 
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Open-ended questions were used to identify sources of stroke information. 
The respondents were asked to name up to three different sources. 
Respondents were also asked if they remembered seeing advertisements 
regarding stroke during the latest months, and those who answered yes were 
given a second open-ended question to determine where they had seen it 
(answers were categorized as: television, newspaper, digital, other). 
Respondents were asked what they would do if they witnessed someone 
having a stroke, or if they themselves experienced sudden stroke symptoms. 
Predefined acceptable answer patterns considered as intent to call 112 
(except the actual answer “call 112”) were the responses “call SOS” and 
”call an ambulance” in combination with the response “112” to the 
subsequent query about which phone number to use in order to activate such 
emergency services.  
Open-ended questions were used to assess the knowledge of the AKUT test. 
They were asked if they ever had heard about the AKUT test, and if they 
could state the significance of each letter. The respondents were then asked 
to name up to three symptoms for stroke. The options predetermined to be 
considered as correct were difficulty understanding or slurred speech, 
trouble walking/dizziness/loss of balance, unilateral numbness, unilateral 
weakness, headache and vision problems. The survey also included 
questions about demographics, such as highest level of education, marital 
status and country of birth.  
The questionnaire used for surveys 1-6 included open-ended questions to 
assess the respondents´ general knowledge about risk factors for stroke. The 
respondents were asked to name up to three risk factors. Predefined answer 
options considered as correct were smoking, hypertension, heart/ 
cardiovascular disease, diabetes, high serum cholesterol, heredity for 
stroke/TIA, psychological stress, lack of physical activity, alcohol 
overconsumption, unhealthy diet, obesity, depression, high intake of sodium 
chloride and high age. Surveys 1-6 also included questions about previous 
diagnoses constituting personal risk factors for stroke. This specific part of 
the questionnaire was excluded for surveys 7-8, as the contribution from 
these questions was considered negligible during this last part of the follow-
up assessments. 
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Study III, a register based study  
The variables used to measure campaign effects on behavior and 
consequences were (1) proportion arriving at hospital within three hours 
from stroke onset and (2) proportion receiving recanalization therapy. The 
registers below were used for collecting data to study III. Data from the 
registers was linked through patients´ unique personal identity number. 
 
Riksstroke: 
The Swedish Stroke Register, Riksstroke, was established in 1994 to 
monitor, support, and improve the quality of stroke care in Sweden. All 
hospitals admitting acute stroke patients in Sweden participate (72 hospitals 
in 2017). Coverage was calculated at 90.5%, based on comparisons with the 
routine hospital discharge register. Validations show considerable over 
diagnosis of acute stroke in routine clinical practice. Allowing for this, the 
Riksstroke coverage is 96.5% (2010) (107). The register includes 
information about age, sex, stroke subtype, living conditions prior to stroke, 
time for stroke onset, time for arrival to the hospital, recanalization therapy 
data and level of consciousness upon admission at the hospital.  
 
Statistics Sweden (The Total Population Register): 
The Total Population Register is maintained by Statistics Sweden and is the 
basis for all official population statistics. Since 1969, this register has been 
the base register for the official Population Statistics and is updated daily 
with data on population changes from The Swedish Tax Agency. For the 
purpose of our study, information about educational level, country of birth, 
and community size were obtained from this register.  
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Study IV, a prospective controlled study 
A neurologist examined the patients before, two and 30 days after carotid 
surgery. Data was prospectively documented in electronic case record forms 
and compiled in a predefined database. Doppler ultrasound scanning was 
used to assess the degree of carotid artery stenosis. Brain CT was performed 
in all patients with cerebral hemisphere TIA or stroke (i.e. all patients except 
those with retinal ischemia) in order to rule out hemorrhage and other 
differential diagnoses. In addition, patients with stroke underwent Diffusion 
Weighted MRI to rule out large-sized infarcts not suitable for early carotid 
surgery (Figure 7). 
To reduce selection bias, a fast track for patients with recent symptoms was 
introduced with the purpose to enable CEA within 48 hours for all patients 
seeking care within 24 hours. Patients considered eligible were investigated 
with carotid Doppler ultrasound within two hours (daytime). If a 
symptomatic significant carotid stenosis was found, the investigation was 
supplemented with acute neuro-imaging, which was deemed necessary in 
order to facilitate a fast treatment decision.   
The primary endpoint was the composite of death and/or any stroke within 
30 days of the surgical procedure. Secondary outcomes were any stroke, 
ipsilateral stroke and ischemic ipsilateral stroke within 30 days of the 
surgical procedure (Figure 7).  
 
Study IV, power and sample size  
With a power of 80%, a 6% increase of complications measured as primary 
outcome could be detected with a total of 600 patients, and 150 patients 
undergoing CEA within 48 hours (p < 0.05). During study planning, we 
estimated that about 35 patients annually would undergo CEA within 48 
hours after the ischemic event, rendering a study duration of 4-5 years.  
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Figure 7: Diagnostic work-up. TIA = transient ischemic attack; Afx = 
amaurosis fugax; RI = retinal infarction; CT = computed tomography; MRI 
= magnetic resonance imaging; CEA = carotid endarterectomy. 
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Statistics 
Descriptive statistics are presented as frequencies or mean values and 
standard deviations. For comparison between groups Student´s t-test or 
Fisher´s Exact test was used for dichotomous variables, the Mantel-Haenszel 
Chi Square test for ordered categorical variables, the Chi Square test for non-
ordered categorical variables, and the Mann-Whitney U-test for continuous 
variables. Odds ratio (OR) were calculated using logistic regression analyses 
and are expressed as OR with 95% confidence intervals (CI) and/or with p-
values. All p-values are two-tailed and p < 0.05 was regarded as significant.  
In study I, multivariable logistic regression analysis was used to identify 
independent factors associated to knowledge of > 3 symptoms, > 3 risk 
factors for stroke, and intent to call 112. Variables included in the 
multivariable models were selected by univariable analysis at p < 0.05. 
In study II, multivariable logistic regression analysis was used to investigate 
the campaign effect on knowledge of the AKUT test, and intent to call 112. 
Variables included in the multivariable models were selected by univariable 
analysis at p < 0.05 plus predefined possible confounders (sex, age and 
education).  
In study III, multivariable logistic regression analysis was used to investigate 
the campaign effect on the proportion of patients arriving at hospital within 
three hours from stroke onset and the proportion receiving recanalization 
therapy. Variables included in the multivariable models were predefined 
possible confounders (age, sex, education, country of birth, community size, 
living alone at stroke onset, previous stroke, ADL-independent before stroke 
onset, living in an institution before stroke onset, level of consciousness and 
for arrival at hospital within three hours also stroke subtype). 
In study IV, for the primary endpoint, variables with p < 0.1 in the 
univariable logistic regression analyses were included in a multivariable 
model.  
Interaction analysis was used in study II to investigate factors associated 
with increased improvement during the study period. In study III Cochran-
Armitage test for trend was used to test the significance in trends. 
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In study I and II, SAS 9.2 (SAS Institute Inc., Cary, NC, USA) was used for 
the statistical analyses. In study III and IV the Statistical Package for Social 
Sciences for Windows (SPSS, Armonk, NY, USA) was used for statistical 
analyses, version 22.0 in study III and version 23.0 in study IV.   
 
Ethical approvals 
The effect of the Swedish National Stroke Campaign was followed up by 
information from registers and telephone interviews. The register-study 
(study III) was approved by the regional ethical board of Gothenburg 
(reference number 551-12). SALAR commissioned a professional telephone 
interviewing company to carry out the telephone interviews, as a part of the 
campaign, to continuously evaluate the campaign effect. Some of the results 
have been presented previously in Swedish media. The data from the 
interviews was primarily collected in a database and did not included data 
that could identify a person (no unique personal identity number or date of 
birth). The called telephone number was not registered and there was no 
existing code list that could identify the person after the interview. Data were 
saved totally anonymized. The research group had access to the material as a 
third part, without handling any personal data in the research project. Ethical 
vetting was therefore judged not to be applicable for this specific part of the 
project. In the Carotid Alarm Study (study IV), written informed consent 
was obtained from all participants. The regional ethical board of Gothenburg 
approved the study (reference number 567-09). 
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Results 
 
Study I 
The response rate was 62%. Reasons for not completing the interview were: 
the telephone interview was refused (26%), the recipient proved unavailable 
despite multiple callbacks during the study period (10%), language barriers 
(1%), and illness (1%). Compared with the Swedish resident population aged 
18-79 years, respondents were more likely to be older and born in Sweden. 
 
Intent to call 112 for stroke symptoms 
Less than two-thirds (65%) indicated that they would call 112 if they 
witnessed or experienced stroke symptoms. Intent to call 112 was found to 
be poorer in men and those with lower levels of education. Increased age 
was associated with a significantly lower intent to call 112 for stroke 
symptoms (Figure 8 and Table 2).  
Seventy-two percent of those who could name at least three stroke symptoms 
reported that they would call 112 compared to 60% of those with no correct 
responses (p < 0.001). However, of those who reported intent to call 112 for 
stroke symptoms, 26% were unable to report any correct stroke symptom. 
 
Knowledge about stroke symptoms 
The most commonly reported stroke symptom was difficulty with 
understanding or slurred speech (reported by 39% of the participants), 
followed by unilateral numbness and unilateral weakness, both reported by 
22%. Seventy-two percent could correctly report at least one, 43% at least 
two, and 13% three or more stroke symptoms. Similar to intent to call 112, 
men and those with lower levels of education had poorer knowledge of 
stroke symptoms (Figure 8 and Table 2). 
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Knowledge about risk factors 
Smoking, reported by 40%, was the most commonly known risk factor 
followed by psychological stress (30%) and hypertension (28%). Overall, 
86% named at least one correct risk factor, 69% at least two, and 46% 
correctly listed three or more risk factors. Also for stroke risk factors, men 
and those with lower levels of education showed poorer knowledge (Figure 8 
and Table 2). 
Respondents with self-reported risk factor(s) did not indicate more correct 
risk factors or stroke symptoms than those without. However, they were 
more likely to name their own risk factor as a stroke risk factor. 
 
Figure 8. Intent to call 112, knowledge about stroke symptoms and 
knowledge about risk factors, over all, by sex, age and level of education 
(%). N = 1443. 
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Factor Univariable logistic 
regression analysis 
Multivariable logistic 
regression analysis                                                    
 Odds Ratio 
(95% CI) 
p-value Odds Ratio 
(95% CI) 
p-value 
Intent to call 112 
                
    
Age, per year 0.98 (0.97–0.99) < .0001 0.99 (0.98–0.99) 0.0002 
Female 1.59 (1.27–1.98)  < .0001 1.48 (1.18–1.85) 0.0007 
Education     
    Primary school         1.00  1.00  
    Elementary school 0.80 (0.54–1.21) 0.2907 0.79 (0.52–1.99) 0.2545 
    High school 1.63 (1.20–2.23) 0.0018 1.28 (0.92–1.78) 0.1504 
    University 1.68 (1.23–2.30) 0.0012 1.40 (1.01–1.93) 0.0434 
Knowledge of ≥ 3 
stroke symptoms                                                    
    
Age, per year 1.00 (0.99–1.01) 0.5503   
Female 1.82 (1.34–2.48) 0.0001 1.79 (1.30–2.45) 0.0003 
Education     
    Primary school         1.00  1.00  
    Elementary school 2.06 (1.10–3.87) 0.0245 2.14 (1.14–4.03) 0.0187 
    High school 1.43 (0.85–2.41) 0.1777 1.37 (0.81–2.31) 0.2413 
    University 2.46 (1.49-4.07) 0.0004 2.30 (1.38-3.80) 0.0013 
Knowledge of ≥ 3 
risk factors 
    
Age, per year 1.00 (1.00–1.01) 0.1928   
Female 1.37 (1.11–1.69) 0.0030 1.29 (1.04–1.60) 0.0207 
Education     
    Primary school         1.00  1.00  
    Elementary school 1.74 (1.14–2.64) 0.0098 1.71 (1.12–2.61) 0.0127 
    High school 1.91 (1.39–2.61)  < .0001 1.83 (1.33–2.52) 0.0002 
    University 2.96 (2.15–4.08) < .0001 2.80 (2.03–3.86) < .0001 
Table 2. Univariable and multivariable logistic regression analysis; factors 
associated with intent to call 112, knowledge of ≥ 3 stroke symptoms and 
knowledge of ≥ 3 risk factors for stroke (n=1443). 
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Study II 
Compared with the Swedish resident population aged 18-79 years, 
respondents were more likely to be older and born in Sweden. During the 
study period, the response rate declined gradually from 62% to 36%, mainly 
because of an increased proportion of people not available despite multiple 
callbacks (Figure 9).  
 
 
Figure 9. Completed interviews, and reasons for not completing the 
interviews (numbers).  
 
Campaign exposure 
Before the campaign started, 28% of the respondents reported that they had 
noticed recent stroke advertisements, compared to 52% during the campaign. 
Television was the most frequently reported source of advertisement. 
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The AKUT test 
Before the campaign started, 15% of the respondents had heard about the 
AKUT test. During and directly after the campaign the proportion increased 
to 51%. By 21 months post-campaign, the proportion that had heard of the 
AKUT test remained unchanged at around 50% (Table 3). The proportion of 
respondents who had heard about the AKUT test increased in all subgroups 
(i.e. sex, age, and educational level). However, knowledge about the AKUT 
test was consistently higher among women and respondents with higher 
levels of education (Figure 10 and 11). Relative improvement during the 
course of the campaign was independent of sex and educational level. By 
contrast, we found that older individuals’ knowledge of the AKUT test 
improved less (Figure 12).  
Before the campaign started, 4% could recall the meaning of some or all 
keywords in the AKUT test, compared with 23% during and directly after 
the campaign, and 14% 21 months later. 
 
Impact on intent to call 112  
Intent to call 112 when experiencing or observing a potential stroke 
increased from 65% pre-campaign to 76% during and directly after the 
campaign. By 21 months after the campaign, intent to call 112 was 73% 
(Table 3). Compared with during and directly after the campaign, the 
proportion that indicated intent to call 112 was slightly but significantly 
lower at 21 months after the campaign; 76% vs. 73% (OR 0.87; 95% CI 
0.76-0.99). Similar to the AKUT test, intent to call 112 increased in all 
subgroups (i.e. sex, age and education level) during the campaign, and intent 
to call 112 remained consistently higher among women and respondents 
with higher levels of education. Also in line with the effects on the AKUT 
test, the relative improvement for intent to call 112 was independent of sex 
and educational level, but dependent on age as we found that older 
individuals improved less (Figure 12). 
Annika Nordanstig 
 52 
 
 
Table 3. Stroke awareness (the AKUT test) and intent to call 112 pre-
intervention compared with 21 months after the end of the campaign. Odds 
ratios (ORs) and adjusted ORs were calculated using logistic regression 
analysis. aAdjusted for sex, age, education, smoking, diabetes, relative that 
has had a stroke, physical inactivity and overweight. 
 
 
 
 
 
 
 
Variable Before the 
campaign 
n=1443 
21 months 
after the 
campaign 
n=1518 
OR (95% CI) Adjusted 
OR (95% CI)a 
AKUT test     
Have heard about 
the AKUT test 
213 (15%) 753 (50%) 1.28 (1.25-1.31) 1.30 (1.26-1.33) 
Can recall all 
keywords in the 
AKUT test 
4 (0.3%) 35 (2%) 1.36 (1.17-1.57) 1.34 (1.15-1.55) 
Can recall some/all 
keywords in the 
AKUT test 
55 (4%) 220 (14%) 1.23 (1.18-1.29) 1.23 (1.17-1.28) 
112     
Intent to call 112 937 (65%) 1109 (73%) 1.06 (1.03-1.08) 1.05 (1.03-1.08) 
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Figure 10. Respondents (%) recalling having heard about the AKUT test, by 
sex. aDirected to the general public. bDirected primarily to workplaces and 
sport clubs. cDirected primarily to men and younger individuals.  
 
 
Figure 11. Respondents (%) recalling having heard about the AKUT test, by 
level of education. aDirected to the general public. bDirected primarily to 
workplaces and sport clubs. cDirected primarily to men and younger 
individuals.  
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Figure 12. Improvement in different age groups on knowledge of the AKUT 
test ant intent to call 112 (%). aSignificant interaction between age and 
improvement, p < 0.0001, bSignificant interaction between age and 
improvement, p = 0.0028. 
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Study III  
A flow chart illustrating the study population is given in Figure 13. The 
demographics were similar over time (Table 4). 
 
 
Registered stroke in the Swedish Stroke Register Oct 2010 to Dec 2014, > 18 y 
n = 104 527 
  
                                                              
                                                                
                                                               
                                       
 
 
 
 
 
 
 
 
 
 
Figure 13. Flow chart of the study population.  
 
Excluded: 
Intracerebral hemorrage, n = 12 179 
Unspecified stroke, n = 1192 
Excluded: 
No Swedish personal identity number, n = 646 
Already hospitalized at the stroke, n = 6041 
 
 
Ischemic stroke patients > 18 y, n = 84 469 
Excluded: 
Patients > 80 y, n = 36 216 
 
Ischemic stroke patients 18-80 y, for 
analyses of the proportion receiving 
recanalization therapy, 
n = 48 253 
Excluded: 
Time from stroke onset to 
admission time is missing 
n = 14 251 
Stroke patients > 18 y with data 
about time from stroke onset to 
hospital admission, for analyses of 
the proportion arriving at hospital < 3 
hours from stroke onset, 
n = 83 589 
 
Study population, n = 97 840 
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Table 4. Demographics of the study population. Discrepancies between the 
proportion and the number for individual variables are due to missing data. 
aBefore stroke onset. 
Variable 
 
12 months pre 
campaign,      
n = 23 702 
 
27 months 
during the 
campaign,   
n = 52 054 
 
 
12 months 
post 
campaign,   
n = 22 084 
 
 
Sex    
   Male, n (%) 12144 (51) 27997 (52) 11577 (52) 
   Female, n (%) 11558 (49) 25057 (48) 10507 (48) 
Age group     
   18-54 y, n (%) 1343 (5.7) 3122 (6.0) 1336 (6.0) 
   55-64 y, n (%) 2484 (10) 5649 (11) 2273 (10) 
   65-74 y, n (%) 5395 (23) 12065 (23) 5365 (24) 
   75-84 y, n (%) 7675 (32) 16406 (32) 6816 (31) 
   85+ y, n (%) 6805 (29) 14812 (28) 6294 (29) 
Education    
   Primary school, n (%) 11149 (45) 23420 (45) 9460 (43) 
   Secondary school, n (%) 10038 (42) 22644 (44) 10006 (45) 
   University >3 years, n (%) 1953 (8.2) 4895 (9.4) 2199 (10) 
Country of birth     
   Sweden and other Nordic, n (%) 22066 (93) 48414 (93) 20446 (93) 
   Other European, n (%) 705 (3.0) 1560 (3.0) 671 (3.0) 
   Other, n (%) 923 (3.9) 2070 (4.0) 962 (4.4) 
Community size    
   > 200 000, n (%) 7233 (31) 15187 (30) 6359 (29) 
   40 000-200 000, n (%) 8813 (38) 19908 (39) 8454 (39) 
   < 40 000, n (%) 7267 (31) 16050 (31) 6816 (32) 
Living conditions    
   Living alonea, n (%) 11891 (50) 25910 (50) 10885 (50) 
   Previous stroke, n (%)                       5871 (25) 12595 (24) 5121 (23) 
   ADL-independenta, n (%)                               19558 (84) 42995 (84) 18214 (84) 
   Living in an institutiona, n (%)       2475 (10) 5148 (9.9) 2230 (10) 
Level of consciousness    
   Alert, n (%) 19347 (82) 42683 (83) 18339 (84) 
   Drowsy, n (%) 2877 (12) 6161 (12) 2483 (11) 
   Unconscious, n (%) 1261 (5.4) 2540 (4.9) 1031 (4.7) 
Stroke subtype    
   Ischemic, n (%) 20434 (86) 44966 (86) 19069 (86) 
   Haemorrhagic, n (%) 2898 (12)  6461 (12) 2820 (13) 
   Unspecified, n (%) 370 (1.6) 627 (1.2) 195 (0.9) 
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Arrival at hospital within three hours from stroke onset    
Time from stroke onset to hospital admission could be determined in 80.4% 
of the patients the year before the campaign started, in 86.4% during and in 
88.7% the year after the campaign. The proportions of patients arriving at 
hospital within three hours from stroke onset at each quarter during the study 
period are given in Figure 14. A significant positive trend was seen only 
during the campaign (p = 0.033).  
The year before the campaign started, 36.3% of the stroke patients arrived at 
hospital within three hours from stroke onset. This proportion increased to 
37.2% in the last twelve months of the campaign and 37.4% the year after 
the campaign (before vs during the campaign; p = 0.364, before vs after the 
campaign; p = 0.029, and during vs after the campaign; p = 0.094). The 
crude odds ratio of arriving at hospital within three hours for the last twelve 
months of the campaign compared to the twelve months before the campaign 
was 1.04 (0.97 to 1.08). However, after adjustment for predefined possible 
confounders, there was a significant association between arrival at hospital 
within three hours and the last twelve months of the campaign (OR 1.05; 
95% CI 1.00-1.09). 
 
 
Figure 14. Proportion (%) arriving at hospital within three hours from stroke 
onset. p-values from Cochran-Armitage test for trend. 
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Recanalization therapy  
Data about recanalization therapy could be determined in > 99% of all 
patients with ischemic stroke aged 18-79 years. The proportions of patients 
receiving recanalization therapy at each quarter during the study period are 
given in Figure 15. A significant positive trend was seen only during the 
campaign (p < 0.001). The year following the campaign there was no further 
improvement, but the proportion receiving recanalization therapy remained 
stable.  
The year before the campaign start, 10.3% received recanalization therapy. 
This proportion increased to 13.3% in the last twelve months of the 
campaign and 13.2% the year after the campaign (before vs during the 
campaign; p < 0.001, before vs after the campaign; p < 0.001, and during vs 
after the campaign; p = 0.190). The crude odds ratio of receiving 
recanalization therapy for the last twelve months of the campaign compared 
to the twelve months immediately before the campaign was 1.33 (95% CI 
1.23-1.45). This association remained significant after adjustment (OR 1.34; 
95% CI 1.24-1.46).  
 
Figure 15. Proportion (%) receiving recanalization therapy (patients 18-80 y 
with ischemic stroke). p-values from Cochran-Armitage test for trend. 
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Study IV 
Of the 466 patients identified as eligible for the study, 418 (90%) gave their 
informed consent to participate in the study (Figure 16).  
After a study duration of five years, only 75 out of the estimated 150 patients 
were operated on within 48 hours. The number of patients with CEA within 
48 hours was hence substantially lower than expected, and also decreased 
during the course of the study. Given the slow and descending inclusion 
rates in the very urgent CEA group, we found it unrealistic to include 150 
patients with very urgent CEA in a foreseeable future. The study was 
therefore prematurely terminated on December 31, 2015. Baseline 
demographics, risk factors and technical data of the study population are 
presented in table 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. A flow diagram of all patients treated by carotid endarterectomy 
(CEA) at the two participating centers. IVT = Intravenous thrombolysis. 
102 patients received CEA at 
Södra Älvsborg Hospital 
544 patients received CEA at 
Sahlgrenska University Hospital 
Excluded patients: 
CEA > 14 days, n = 5   
Stenosis < 50%, n = 11 
 
 
Excluded patients: 
CEA > 14 days, n = 133                     
IVT before, n = 17                             
Not residing in South West 
Region of Sweden, n = 2                                    
Stenosis < 50%, n = 8               
Asymptomatic stenosis, n = 4 
 
 
380 eligible patients 
 
 
86 eligible patients 
 
 
418 patients included 
 
 
No consent, n = 27     
Language barrier, n = 4 
 
 
No consent, n = 15     
Language barrier, n = 2 
 
 
Annika Nordanstig 
 60 
Delay to carotid endarterectomy from onset of 
most recent ischemic event 
 
< 48 hours 
(n = 75) 
48 hours - 14 
days (n = 343) 
Age, mean (SD) 73.1 (8.5) 73.7 (8.5) 
Female, n (%) 20 (27) 106 (31) 
Functional outcome before surgery (mRSa < 2) 70 (93) 324 (94) 
Degree of stenosis (NASCETb)   
   50-69%, n (%) 16 (21) 101 (29) 
   70-99%, n (%) 59 (79) 242 (71) 
Degree of contralateral stenosis (NASCETb)   
   < 50%, n (%) 66 (88) 251 (73) 
   50-69%, n (%) 4 (5) 33 (10) 
   70-99%, n(%) 5 (7) 42 (12) 
   Occlusion, n(%) 0 (0) 17 (5) 
Qualifying eventc   
   Amaurosis fugax/Retinal occlusion, n (%) 18 (24) 82 (24) 
   TIA, n (%) 28 (37) 106 (31) 
   Crescendo TIA, n (%) 14 (19) 17 (5) 
   Minor stroke, n (%) 15 (20) 137 (40) 
   Major stroke, n (%) 0 (0) 1 (0,3) 
New ischemic event after the event that 
brought the patient to hospital, n (%) 
37 (49) 37 (11) 
New stroke after the event that brought the 
patient to hospital, n (%) 
7 (9) 6 (2) 
Risk factors   
   Diabetes mellitus, n (%) 15 (20) 76 (22) 
   Hypertension, n (%) 58 (77) 264 (77) 
   Current smoking, n (%) 16 (21) 80 (23) 
   Coronary artery disease, heart failure, n (%) 27 (36) 117 (34) 
   Pulmonary disease, n (%)d 5 (7) 31 (9) 
Surgery during out of office hours, n (%) 37 (49) 152 (44) 
Days between the qualifying event and CEA, 
mean (SD) 
1.3 (0.69) 6.7 (2.9) 
 
Table 5. Baseline demographics, risk factors and technical data of the study 
population. aThe modified Rankin Scale. bThe North American Symptomatic 
Carotid Endarterectomy Trial. cMost recent ischemic event proceeding 
surgery. dSymptomatic chronic obstructive pulmonary disease.  
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Primary and secondary outcomes 
Patients undergoing CEA within 48 hours from the most recent event had a 
significantly higher risk of the combined primary endpoint of mortality 
and/or any stroke compared with the group treated 48 hours to 14 days after 
an ischemic event; 8.0% versus 2.9% (OR 2.90; 95% CI 1.02–8.23), see 
Table 6. The characteristics of the 16 patients who suffered a complication 
are shown in Table 7. Multivariable logistic regression analyses showed that 
CEA performed within 48 hours (OR 3.07; 95% CI 1.04–9.09), CEA 
performed out of office hours (OR 3.65; 95% CI 1.14–11.67), and use of 
shunt (OR 4.02; 95% CI 1.36–11.93) were all independently associated with 
an increased risk of reaching the primary endpoint.  
 
 
Table 6. Primary and secondary outcomes. aStatistical analysis by Fisher´s 
exact test. bCarotid endarterectomy. cBivariable odds ratio (OR) and 95% 
confidence intervals (CIs) were calculated using logistic regression analysis. 
 
Post hoc analysis 
Post hoc analysis showed that the combined mortality and/or stroke rate for 
patients operated within 48 hours from the event that brought the patient to 
hospital was 10.9% (five out of 46 patients). In contrast, the combined 
mortality and/or stroke rate for patients operated on within 48 hours from the 
most recent event, but more than 48 hours from the event that brought the 
patient to hospital was only 3.4% (one out of 29 patients). 
 
Primary and secondary outcomes < 48 h 
n = 75 
48 h–14 d 
n = 343 
p-valuea OR very urgent 
CEAb 
(95% CI)c 
Stroke and/or death, n (%) 6 (8.0) 10 (2.9) 0.049 2.90 (1.02-8.23) 
Stroke, n (%) 6 (8.0) 9 (2.6) 0.035 3.23 (1.11-9.36) 
Ipsilateral stroke, n (%) 6 (8.0) 7 (2.0) 0.016 4.17 (1.36-12.80) 
Ipsilateral ischemic stroke, n (%) 6 (8.0) 5 (1.5) 0.006 5.88 (1.75-19.81) 
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Table 7. Characteristics of the patients who suffered a primary endpoint. F = 
Female; M = Male; Afx = Amaurosis fugax; cTIA = Crescendo TIA; RI = Retinal 
infarction; mRS = The modified Rankin Scale; Preop = preoperative; CEA = Carotid 
endarterectomy. aMost recent ischemic event preceding surgery. bTime to surgery 
was calculated as time from the most recent ischemic event preceding surgery. 
cObserved by neurologist at day two. dSymptom onset a few hours postoperatively. 
eNo evidence for hyperperfusion syndrome (no hypertension and no headache).  
Sex, 
age 
Type of 
eventa 
Preop  
mRS 
Time to 
CEAb 
Endpoint, timing and type of 
endpoint 
mRS at 
day 30 
F, 75 Stroke 1 9 d Day 3e, ipsilateral hemorrhagic 
stroke, death 
6 
F, 67 Afx 1 2 d Day 0-2c, Ipsilateral ischemic 
stroke 
2 
M, 62 TIA 0 4 d Day 0d, Ipsilateral ischemic stroke 
 
1 
M, 72 Stroke 1 3 d Day 0d, Ipsilateral ischemic stroke 
 
3 
M, 70 Stroke 1 3 d Day 0-2c, Ipsilateral ischemic 
stroke 
0 
M, 78 TIA 1 5 d Day 1, Contralateral ischemic 
stroke 
0 
M, 79 Stroke 2 6 d Day 28, Contralateral ischemic 
stroke 
1 
M, 69 TIA 0 9 d Day 2e, Ipsilateral hemorrhagic 
stroke 
5 
M, 82 Stroke 1 6 d Day 28, Death (in sepsis) 
 
6 
F, 75 RI 1 6 d Day 0d, Ipsilateral ischemic stroke 
 
0 
M, 83 TIA 0 <48 h Intraoperative, Ipsilateral 
ischemic stroke 
1 
M, 74 Stroke 3 <48 h Intraoperative, Ipsilateral 
ischemic stroke 
3 
M, 72 Afx 0 <48 h Day 1, Ipsilateral ischemic stroke 
 
5 
F, 81 cTIA 2 <48 h Day 0-2c, Ipsilateral ischemic 
stroke 
2 
F, 79 TIA 0 <48 h Intraoperative, Ipsilateral 
ischemic stroke 
4 
M, 74 Stroke 1 <48 h Intraoperative, Ipsilateral 
ischemic stroke 
4 
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Discussion 
 
General discussion 
The aim of this thesis was to generate knowledge that can improve timely 
acute treatment and secondary prevention in patients with acute 
cerebrovascular events. As “time is brain” both with respect to acute 
treatment and secondary prevention, such knowledge may, by a reduction of 
both the acute brain injury and the devastating effects of a recurrent stroke, 
increase the number of people surviving an acute stroke with no or only 
minor disability. 
With respect to acute treatment, the focus was on reducing patients´ delay to 
activation of emergency services. In the first study, we confirmed a rather 
low public awareness of stroke in Sweden, justifying the efforts of the 
educational Swedish National Stroke Campaign launched by the Swedish 
Authorities. Next, we compared data from telephone surveys and national 
registers before, during and after the Swedish National Stroke Campaign and 
found significant improvements in stroke awareness in the general 
population as well as an increased proportion of patients receiving 
recanalization therapy, coinciding with the time for the campaign. A small 
but significant improvement regarding the proportion arriving to the hospital 
within three hours was also observed. 
With respect to timely secondary prevention, the focus was on very urgent 
carotid surgery in patients with symptomatic carotid stenosis, investigating 
the hypothesis that very urgent surgery is not associated with an increased 
procedural risk compared to surgery performed later. However, opposite to 
our hypothesis, we found that very urgent surgery (within 48 hours of an 
ipsilateral cerebrovascular ischemic event) was associated with an increased 
risk of primary endpoint death and/or any stroke within 30 days of the 
surgical procedure compared with surgery performed 48 hours to 14 days 
after the event. 
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Public stroke awareness in Sweden 
The inability to recognize stroke symptoms and to act optimally has been 
suggested to constitute the single most important factor explaining patients´ 
delay to activating emergency services, and thus also an important barrier for 
use of recanalization therapy in eligible cases (45). In this first study of 
stroke awareness, conducted in the general Swedish population, we confirm 
a rather low public awareness of stroke. Only about one out of ten could 
report three or more stroke symptoms and about two thirds indicated intent 
to call 112 when witnessing or experiencing a potential stroke. This is in line 
with findings from similar studies conducted in other countries (2). Men and 
those with lower level of education had poorer knowledge of stroke 
symptoms and risk factors. Among men there are also a significantly lower 
proportion that indicated intent to call 112 for stroke symptoms. In contrast 
to other studies (49), increased age was not associated with lower knowledge 
of risk factors and stroke symptoms. However, with increasing age a lower 
proportion indicated intent to call 112 if experiencing or witnessing a 
potential stroke, suggesting that elderly may have a higher threshold for 
activating emergency services. Earlier studies show that minority ethnic 
groups have constantly been reported to have poor stroke knowledge (49, 
108). Study I included only those able to speak Swedish, why it is unclear 
whether non-Swedish speaking individuals were reached by the campaign. 
 
Did the Swedish National Stroke Campaign increase 
stroke knowledge and intent to call 112? 
Study II showed improved public stroke awareness both with respect to 
stroke knowledge and intent to call 112 during the campaign. Of note, the 
rate of improvement was higher during the first, most intensive part of the 
campaign and remained stable or decreased after the campaign ended, 
indicating that the observed improvements was an effect of the campaign. 
Similar results have been reported previously. One review (56), including 22 
studies of educational stroke campaigns, concluded that all studies but one 
proved partially effective with respect to stroke awareness.  
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The only negative study was a four year long national campaign in the Czech 
Republic (60), differing from the others with respect to lower intensity and a 
very small budget (< 5% of the budget for the Swedish National Stroke 
Campaign). 
It is also of note that the changes that occurred during the campaign closely 
coincided with the execution of the campaign. For instance, the proportions 
that had heard about the AKUT test and that could recall some or all 
keywords markedly increased during the first, most intensive, part of the 
campaign and the proportion that had heard about the AKUT test remained 
stable thereafter. In contrast, the proportion that could recall some or all 
keywords decreased during the latter part of the campaign, a period during 
which the campaign did not describe the AKUT keywords in detail.  
Moreover, to reach men better, the latter part of the Swedish National Stroke 
Campaign linked advertising to sport programs, a context considered more 
appealing to men. After this specific part that targeted men, the rate of 
improvement regarding the knowledge about the AKUT test increased 
among men. These efforts may explain why this campaign reached men 
better than what was reported from another study (57) that found that 
women’s knowledge improved more during a campaign. In our study, there 
was no sex difference in knowledge improvement. Also, the relative 
improvement during the course of the campaign for both stroke knowledge 
and intent to call 112 was independent by educational level despite 
differences in level of knowledge pre campaign. 
In line with previous reports (62, 109), we found that elderly improved less 
during the course of the campaign, both with respect to intent to call 112 and 
knowledge about the AKUT test.  
The observed changes during and after the Swedish National Stroke 
Campaign differs compared to other studies with respect to post campaign 
changes (61). Compared with previous stroke campaigns, there was a 
relatively modest decline in public knowledge post campaign, which may be 
explained by the additional web-based follow-up campaign. However, it is 
reasonable to assume that more intensive follow-up campaigns are needed to 
sustain the gains.   
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In conclusion, results from study II supports that the Swedish National 
Stroke Campaign increased public knowledge of the AKUT test and the need 
to call 112 when experiencing or witnessing a stroke, but intent to call 112 
declined post-intervention. The greatest improvements occurred during the 
most intensive part of the campaign. Taken together, these results indicate a 
close relation between campaign intensity and effects and that repeated 
public information are essential to sustain the gains. Better strategies to 
reach older people are needed as this group improved less, especially as the 
elderly represent an important target for educational campaigns, both 
because this group has lower intent to call 112, but also because they are 
more likely to experience a stroke themselves or to witness it as a bystander.  
 
Did the Swedish National Stroke Campaign influence 
patient behavior (patient delay) consequences of 
behavior (recanalization therapy)? 
Study III demonstrated a significant increased improvement in both the 
proportion receiving recanalization therapy and the proportion arriving at 
hospital within three hours from stroke onset. For both outcomes, a 
significant improvement was seen only during the campaign period, 
indicating an association with the campaign. According to a systematic 
review (55), positive intervention effects were reported in the majority of 
studies. However, the success of a health awareness campaign is dependent 
on a multitude of factors, including the adequacy of funding, frequency of 
advertising, and use of appropriate media (110). A stepped-wedge cluster 
randomized controlled trial (111), with four clusters, did not demonstrate 
any effect on pre-hospital delay. However, the length of the intervention in 
this study was rather short and ranged between three months in the fourth 
and twelve months in the first cluster. A population-based study (112) 
investigating the effect of the FAST campaign in the UK showed marked 
improvement with respect to early presentation after major stroke (defined as 
NIHSS > 3) following the campaign. The FAST campaign was repeated 
regularly during several years. The length and/or repetition of the 
intervention might thus be critical (113).  
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Data on long-term effects from stroke campaigns are scarce. The majority of 
studies examining emergency department presentations for stroke symptoms, 
pre-hospital delay and/or recanalization rates in stroke patients report that 
the effect decline post intervention (63-66). However, a decline post 
intervention was not observed in our study as the proportions receiving 
recanalization therapy remained stable the year following the campaign. A 
possible explanation is an effect from the smaller additional follow-up 
campaign (conducted the year following the main campaign). 
The Swedish National Stroke Campaign was directed towards the general 
population. It was therefore unexpected that there was a greater effect on the 
proportion receiving recanalization therapy than the proportion arriving at 
hospital within three hours. This could partly be explained by the 
shortcomings associated with the outcome variable “arrived within three 
hours from stroke onset”. These shortcomings include imprecise estimations 
of the time for stroke onset reported by patients, bystanders or caregivers, 
and a possible influence of information bias as the proportion with data 
available on time from stroke onset to hospital arrival changed during the 
study period. This may limit the precision of the variable as an outcome 
measure, which is further discussed in the methodological considerations 
below.  
In addition, during the campaign the hospitals also focused on improving the 
quality of in-hospital stroke care and reducing treatment delays. Door-to-
needle times markedly improved during the campaign, after several 
preceding years with only modest improvements (114), which is in line with 
results reported elsewhere (115). Thus, according to the quality register 
Riksstroke, the years before the campaign started, median door-to-needle 
time was almost 70 minutes, and during the campaign the median time 
decreased substantially to 48 minutes in 2013. After the end of the 
campaign, the door-to-needle times have continued to improved but at a less 
rapid pace (45 minutes in 2014, 43 minutes in 2015 and 2016 respectively 
and 39 minutes in 2017), indicating that the observed substantial 
improvement during the campaign period possibly also was related to the 
efforts linked to the Swedish National Stroke Campaign. 
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A similar spillover effect was seen in the pre-hospital HASTA study (116) 
conducted in 2008 in Stockholm, Sweden. Patients with symptoms of stroke 
within six hours were randomized from the emergency medical services to 
either get an ambulance transport immediately (intervention group) or within 
30 minutes (control group and, at that time, standard care). Interestingly, the 
observed in-hospital time reduction was even greater than the pre-hospital 
time reduction, despite the fact that the HASTA trial intervention was pre-
hospital.  
In conclusion, results from study III show that the Swedish National Stroke 
Campaign was associated with a sustained improvement regarding the 
proportion receiving recanalization therapy, and with a small but significant 
improvement regarding the proportion arriving at hospital within three 
hours. 
 
Procedural risk of CEA stratified for delay 
The Carotid Alarm Study (study IV) showed, contrary to our hypothesis, a 
significant increase in procedural risk if surgery was performed within the 
first 48 hours from an ischemic event compared to after 48 hours and up to 
14 days after an ischemic event.  
During the time period when the Carotid Alarm Study was ongoing, a 
number of other studies that investigated urgent carotid surgery were 
published. The reported risk associated with very early carotid intervention 
in these trials was divergent and partially conflicting (96-105, 117-121). The 
divergent findings may partly be explained by differences with respect to 
study design (i.e. prospective cohort studies versus retrospective and 
registry-based studies), inclusion/exclusion criteria and the exact definition 
of the qualifying event. However, there is no clear pattern on how such 
differences between studies influence the results and the overall 
heterogeneity across studies also limits the possibilities for meta-analysis. 
The risk of underestimating complications associated with very urgent 
surgery is higher if a retrospective design is used. Register-studies can either 
be prospective or retrospective depending on when the register is filled in. 
Timely treatment in stroke and TIA 
 
 
69 
Except for the Carotid Alarm Study, we found a few other prospective 
studies (96, 100) (registry-based studies not included). Capoccia et al (96), 
included 48 patients with crescendo-TIA or stroke in evolution and reported 
a mortality and/or stroke rate of only 2.1% (i.e. one patient). Tsivgoulis et al 
(100) included 20 patients operated with CEA within 48 hours from stroke 
onset, of which two (10.0%) patients suffered a stroke.  
In 2015, a meta-analysis (106) showed that early CEA within the first two 
days from a TIA was relatively safe, with a periprocedural stroke risk of 
2.7%. However, when a stroke was the qualifying event, the periprocedural 
risk was substantially higher (8%). Therefore, studies including a higher 
proportion of TIA patients may underestimate the risk, compared with 
studies including a higher proportion of stroke patients. 
The definition of qualifying event differs between studies. In some studies 
the qualifying event was defined as the referring event (i.e. the event that 
brought the patient to the doctor), and in other studies the most recent event 
was defined as the qualifying event. Studies reporting time from the most 
recent event tend to show a lower procedural risk than studies with the 
referral event as qualifying event. Hypothetically, patients with new 
symptoms after seeking medical care (a common situation if the qualifying 
event was defined as the most recent) may have had properly instituted 
medical therapy for a longer time period, which may stabilize the 
atherosclerotic plaque and hence decrease the risk of complications. In the 
Carotid Alarm Study, where the combined mortality and/or stroke rate was 
8.0% in patients undergoing CEA within 48 hours, the qualifying event was 
defined as the most recent event prior to surgery. However, in post hoc 
analysis, the combined mortality and/or stroke rate for patients operated on 
within 48 hours from the event that brought the patient to hospital was 
10.9%. In contrast, the combined mortality and/or stroke rate for patients 
operated on within 48 hours from the most recent event, but more than 48 
hours from the event that brought the patient to hospital was only 3.4% (one 
out of 29 patients). Thus, the differences in definitions of qualifying event 
may affect the risk of a periprocedural stroke. A summary of studies 
analyzing risk of very urgent CEA is presented in Table 8.  
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In addition, with a very urgent treatment approach, both more treatment 
decisions and CEAs will be performed out-of office hours, with potentially 
reduced staffing levels, staffing seniority and supportive services at hospitals 
with worsening patient outcomes. 
Given the diverse results in the literature regarding perioperative risk in very 
urgent carotid CEA, the Carotid Alarm Study adds further evidence in favor 
of a more careful approach with expedited CEA, within the first two days 
after an ischemic event. This is in line with the results presented in a very 
recent published systematic review and meta-analysis (122) that concluded 
that very urgent carotid intervention within the first two days was associated 
with increased risk of stroke within 30 days of treatment compared with 
urgent carotid intervention, 6.6% versus 3.2% (OR 2.19, 95% CI 1.46-3.2). 
However, this meta-analysis did not investigate patients with TIA or stroke 
separately, and therefore it is unclear if there is differences in complication 
frequencies depending on the type of qualifying event. 
Thus, the optimal timing of CEA intervention following symptom onset still 
remains unclear. The anticipated theoretical benefit of very early surgery for 
symptomatic carotid artery stenosis has to be carefully balanced with the 
possibly increased risks associated with early intervention.  
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Table 8. Comparing procedural risk within 48 hours or two days from 
referral event (the event that brought the patient to hospital) or the most 
recent event. Relevant studies, published from 2012-2017, with > 20 patients 
that performed CEA within 48 hours/two days are included. aPost-hoc 
analysis.  
 Country Design 
 
 
 
Time for 
CEA from 
referral 
event/most 
recent 
event 
Patients, 
n 
Stroke/ 
Death,  
n (%) 
Avgerinos 
2017 (117) 
U.S. Register-study, 
multi 
referral 
event 
96 7 (7.3) 
Barbetta 
2014 (97) 
Italy Retrospective, 
single 
referral 
event 
45 2 (4.4) 
Capoccia 
2012 (96) 
Italy Prospective, 
single 
referral 
event 
48 1 (2.1) 
Chisci 
2015 (98) 
Italy Retrospective, 
single 
referral 
event 
30 3 (10.0) 
Loftus 
2016 (118) 
U.K. Register-study, 
national 
referral 
event 
780 29 (3.7) 
Strömberg 
2012 (101) 
Sweden Register-study, 
national 
referral 
event  
148 17 (11.4) 
Tsantilas 
2017 (123) 
Germany Retrospective, 
single 
referral 
event 
60 2 (3.3) 
Tsivgoulis 
2014 (100) 
Greece Prospective, 
multi 
referral 
event 
20 2 (10.0) 
Nordanstig 
2017 
Sweden Prospective, 
two centers 
most recent 
event  
(referral 
event)a 
75  
(46)a 
6 (8.0)  
(5 (10.9))a 
Ferrero 
2014 (102) 
Italy Retrospective, 
single 
most recent 
event 
176 7 (4.0) 
Gajin 2014 
(103) 
Serbia Retrospective, 
single 
most recent 
event 
58 0 (0.0) 
Rantner 
2015 (104) 
Austria Retrospective, 
single 
most recent 
event 
206 9 (4.4) 
Sharpe 
2013 (105) 
U.S. Retrospective, 
single 
most recent 
event 
41 1 (2.4) 
Tsantilas 
2016 (121) 
Germany Register-study, 
national  
most recent 
event 
5198 156 (3.0) 
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Methodological considerations and limitations 
The results of research must always be interpreted in light of the weaknesses 
and strengths of the methods used. When conducting a clinical study there 
are a number of methodological considerations. In the planning phase, these 
include choosing an appropriate study design, recruitment of participants, 
and which specific methods to use. What to choose depends on the research 
question, but also on what is feasible.  
Studies can be descriptive or analytical (effect research) studies. In an 
analytical study, the effect of something is studied, either as an analytical 
observational study (“the natural experiment”) or as an analytical 
experimental study. Approaches such as cohort and case-control studies are 
examples of analytical observational studies. Examples of analytical 
experimental studies are RCTs and community intervention trials (Figure 
17). An analytical study can be a controlled study (with a control group) or 
an uncontrolled study (without a control group). An experimental controlled 
study can further be a randomized controlled study or a non-randomized 
controlled study, in which people are allocated to different interventions using 
methods that are not random. 
 
 
 
 
 
 
 
 
Figure 17: Type of studies. 
 
 
experimental 
analytical (effect research) descriptive 
observational 
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During the course of a study and during the analytical phase unexpected 
issues may occur that may influence the results of the study (124-129). 
Methodological considerations with respect to study design and specific 
method, as well as the most important issues that occurred during the course 
of the studies and during data analysis, are presented below.  
 
Study design 
Descriptive study (study I):   
To investigate public stroke awareness in Sweden, there are no other options 
than to use a descriptive study design. The methodological considerations 
are rather the choice of specific methods (telephone, face-to-face, postal or 
web-based questionnaires), see below. 
 
Uncontrolled before, during and after study (study II and study III) - 
analytical studies: 
The campaign was launched, designed and conducted by SALAR. The 
decision was to make it national and that the whole population should 
benefit. The possibility to perform a study using a regional control group in 
Sweden was not possible. Thus, the choice was to conduct an uncontrolled 
study comparing data from before, during and after the campaign. The main 
limitation however, with such studies is that causation cannot be proven.  
An attractive design would have been a cluster randomized controlled trial. 
In cluster randomized trials clusters of people or communities, rather than 
individuals, are randomized to intervention and controlled groups. Avoiding 
withholding the intervention from a proportion of the participants, a so 
called stepped-wedge cluster randomized controlled trial (SW-RCT) (130) 
can be an alternative. This study design is a relatively new type of cluster 
randomized design. There is a period of baseline data collections, in which 
no clusters are exposed to the intervention. Subsequently, at periodic time 
points (“steps”), one cluster is randomized to cross from control to 
intervention, whereas the remaining clusters remain in the control condition. 
The study continues until all clusters have crossed to the intervention arm, 
and there is usually a period at the end of the study in which all cluster are 
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exposed to the intervention. However, even though this design can offer a 
whole population to be exposed to the campaign, the latest cluster included 
should be exposed for a shorter time period, and as the time exposed to a 
campaign seems to be essential, there may be some ethical considerations 
using this design. 
In conclusion, as we could not influence the design of the campaign, neither 
a cluster randomized controlled study, nor a SW-RCT were feasible 
alternatives. Therefore, we found uncontrolled before, during and after 
studies to be the best alternative available. 
 
A prospective controlled observational study (study IV): 
The optimal study design for comparing acute CEA with subacute surgery is 
a randomized controlled trial (RCT). However, such a study will have to 
incorporate a large number of patients which is only possible as a multi-
national multi-center randomized trial. Moreover, in the view of the 
documented high risk of recurrent events and as no studies at that time 
(before the start of study IV) showed an increased risk of perioperative 
complications with very early CEA (90), a study randomizing patients to 
delayed surgery might have caused difficulties in recruiting patients. Patients 
might have been reluctant to participate and investigators could have 
perceived an ethical dilemma to allocate patients to delayed surgery. 
From our point of view and with the limited resources available, a RCT was 
not feasible and we found a prospective controlled study to be the best 
alternative. Such a study would give information about the procedural risk, 
and if not elevated it would strongly support very urgent surgery. However, 
if only a small proportion of patients are operated on very urgently there is a 
risk of aggregation of patients with unstable symptoms in the group 
undergoing surgery within 48 hours, which is a potential source of bias in 
such studies. To counteract this in the Carotid Alarm Study, we introduced a 
fast track for patients seeking within 24 hours from an ischemic event. 
Besides speeding up the process, the purpose of the fast track was to reduce 
the risk of selection bias in the group undergoing surgery within 48 hours. 
Our intent was to offer urgent surgery within 48 hours to all patients seeking 
within 24 hours from their last ischemic event. However, the use of a fast 
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track in a prospective study may facilitate urgent surgery in stable patients 
while unstable patients with higher risk for complications may be delayed 
due to additional time-consuming evaluations. Therefore, we believe that a 
possible selection bias in this study would, if anything, rather lead to an 
underestimation of the risk of complications associated with urgent surgery. 
  
Specific methods  
Telephone interviews (study I-II): 
The aims of these studies were to evaluate the respondent´s knowledge in the 
area of stroke. It is important that the respondents are unprepared for the 
questions, which is the case when using telephone interviews. Contacting 
respondents by post or by the web would give an opportunity to search for 
the right answers before leaving a response. Therefore, postal or web-based 
surveys are not good alternatives for the evaluation of such knowledge. 
However, respondents have been shown to give more positive and socially 
desirable responses in telephone interviews compared to postal surveys 
(131). Therefore, reporting bias due to socially undesirable behaviors such as 
smoking and physical inactivity are likely to be underestimated in our 
studies. Besides the method of contacting respondents (telephone, face-to-
face, postal or web-based questionnaires), the design of the questionnaire 
influences the answers from the respondents, e.g. if open-ended or closed-
ended questions are used. 
A possible selection bias would be if persons registered (about 75-80% of 
the target population) in the telephone register differ from persons not 
registered. As we do not have information about this, we can only speculate 
if this may have had influenced our results.  
Another limitation is the selection bias with respect to minority ethnic 
groups. The survey was confined to those answering the telephone being 
able to speak Swedish, excluding a number of potential respondents. Results 
therefore cannot be generalized to non-Swedish speaking groups, which is 
important to be aware of because minority ethnic groups have consistently 
been reported to have poor stroke knowledge (49, 108). 
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Register-based study (study III): 
A major strength of register-based studies is the potentially large size of the 
study populations. However, when data on a large numbers of patients are 
collected, detailed information is more difficult to obtain. Most violations of 
validity in a national register based study are the risk of selection bias, 
confounding factors and information bias.  
Selection biases are distortions resulting from the procedures used to select 
study subjects. However, the registers used in study III have a high coverage 
during the study period, minimizing the selection bias. Confounding factors 
are associated with both the exposure and the outcome and they affect the 
true association between exposure and outcome. For instance, many aspects 
might affect onset to admission time, for example, the priority of stroke at 
the SOS-Alarm. Even if there has not been a change in priority for stroke 
patients in the instructions used by SOS-Alarm, they may also have been 
influenced by the campaign. If so, the effect of decreased onset to admission 
time may not reflect decreased patient´s delay but the early care of stroke 
patients. Information bias refers to measurement errors in the information 
needed to estimate an association. This could be caused by, either that 
important information is not registered in the register (predictable when 
planning the study) or missing data (unpredictable when planning the study). 
Examples of missing data in study III are described below. 
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Non-blinded evaluation of outcome (study IV): 
The neurologists that examined the patients 30 days after CEA were not 
blinded with respect to treatment group, rendering a risk for observer bias. 
This bias could have been prevented by using independent clinicians who 
were not involved in the trial to assess patients. However, blinded outcome 
assessment was not practically feasible, as local physicians made the 
assessments and as patients were not blinded.  
However, with the use of objective outcomes (mortality and stroke), non-
blinded assessment was less likely to bias the results. Moreover, when there 
were difficulties to determine if a complication had occurred or not (one 
case), a senior external assessor reviewed the case after the medical record 
was censored from dates (that could reveal if CEA was performed within 48 
hours or not).  
 
Unexpected issues during the course of the studies 
Misclassification in study II: 
The question regarding knowledge about symptoms of stroke was an open-
ended question. Difficulty with understanding or slurred speech, trouble 
walking/dizziness/loss of balance, unilateral numbness, unilateral weakness, 
headache and vision problems were classified as correct answers.  
However, the proportion of respondents registered as correctly answering 
“unilateral weakness” when asked for stroke symptoms showed 
unreasonably large variations between the different surveys. This indicates 
that the interpretation of the answers by the interviewers differed over time 
and the professional telephone interviewing company admitted that the 
instructions to the interviewers seemed to have been too unclear. Thus, there 
is room for different interpretations and potential classification bias. 
Therefore, we concluded that the results for this item were unreliable and we 
decided not to use any of the subqueries of this question in study II as an 
instrument to evaluate the effect of the campaign. Instead, the analyses were 
restricted to knowledge about the AKUT test and intent to call 112. This 
illustrates the importance of performing a face-to-face validation and/or a 
pilot study to identify unforeseen problems. 
Annika Nordanstig 
 78 
Slow inclusion rates in study IV: 
During recruitment, the number of patients with CEA within 48 hours was 
substantially lower than expected, and also decreased during the course of 
the study. During the study period, we continuously investigated reasons for 
delay and took actions for speeding up the inclusion rate. However, given 
the slow and descending inclusion rates in the urgent CEA group, we found 
it unrealistic to include 150 patients with urgent CEA in a foreseeable future. 
Despite the fact that as many as 72% of the participants were admitted to the 
hospital within 24 hours from an ischemic event, only 11% underwent 
surgery within 48 hours. The main reasons for postponed surgery were 
organizational/logistical and not medical. As a consequence of the premature 
termination, this study is limited by a small sample.  
 
Methodological considerations with respect to results and data 
analysis  
Non-response bias (study II): 
The response rate was somewhat low, and declined gradually from 62% to 
36%, primarily because of an increased proportion of people not available 
despite multiple callbacks. According to the professional telephone 
interviewing company, this phenomenon was not unique to our study and 
may relate to an increased use of caller ID display on phones. Non-response 
bias (one reason for selection bias) can become an issue when there are 
distinct differences between the people who participate in the survey and the 
people who do not participate.  
This error’s impact on results cannot easily be quantified as we do not have 
much data on the non-respondents. However, the demographics remained 
stable during all surveys. This may indicate that there were no distinct 
differences between the people who participated and those who did not 
(independent loss of participants).  
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Missing data (study III): 
Our initial aim was to analyze time from stroke onset to contact with 
emergency services and the proportion calling 112. To this end we used the 
unique personal identity number to link data from SOS-Alarm and 
Riksstroke. However, due to a large proportion of cases lacking personal 
identity numbers in the SOS-Alarm register, there was a high rate of non-
linkage between the two registers. Therefore, the analyses were restricted to 
arrival at hospital within three hours and proportion of ischemic strokes 
receiving recanalization treatment.  
Furthermore, the proportion of patients with missing data on stroke onset 
time decreased during the study period. If the improved coverage was biased 
towards those with a more delayed hospital arrival, this could influence the 
results and lead to a reduced sensitivity to detect an increase in the 
proportion arriving at hospital within three hours.  
 
Less sensitive endpoint (study III): 
The outcome proportion of patients arriving at hospital within three hours 
from stroke onset appears to be a less sensitive endpoint, as illustrated by the 
substantial over-representation of reported stroke onset at half- or full hours. 
It thus seems that it is common for patients, bystanders or caregivers to 
estimate stroke onset time without knowing the exact time. This may limit 
the precision of the variable as an outcome measure.  
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Ethical considerations 
There are a number of ethical considerations to take into account when 
planning a study. The scientific benefits must always be carefully weighed 
against the possible negative effects for the participants.  
Ethical issues related to telephone interviews (study I and II), especially on 
sensitive topics, are that they can be perceived as a violation of the personal 
integrity. In the questionnaire used in study I and II, the participants were 
asked about their own risk factors which can be perceived as sensitive issues.  
Register data research (study III) involves processing of personal data, which 
may be considered as an integrity violation. All stroke patients admitted to 
hospitals in Sweden are informed that they are registered in the national 
stroke register (Riksstroke), aiming to improve stroke care. Patients are 
informed that they have the right to non-participation as well as withdrawal 
from the register, and that data may be used for research purposes. However, 
as formal written informed consent is not obtained, there is an inherent risk 
that some patients are not fully informed. 
In the Carotid Alarm Study (study IV) a fast track for patients with recent 
symptoms was introduced, which may have caused delayed management of 
patients not included in the fast track. However, also in routine every day 
care, patients with recent symptoms have the highest priority as they have 
the highest risk for new events.  
In the Carotid Alarm Study, ethical considerations may also include that 
patients may not feel empowered to refuse participation, as they are 
dependent on the doctor and research nurse for their ongoing care. It can also 
take some time for the patient to thoroughly consider whether they want to 
participate in research, and the focus of the consultation may be inadequately 
shifted away from the patient to the research. This ethical dilemma is 
however less apparent in observational than in interventional studies, as 
participation does not affect the given treatment.  
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Conclusion to given aims 
 
 We confirmed a rather low public awareness of stroke in Sweden, 
poorer among men and those with a low level of education. 
With increased age, a lower proportion indicated intent to call 
112 if witnessing or experiencing a potential stroke. 
 
 The Swedish National Stroke Campaign substantially increased 
population knowledge about the AKUT test and intent to call 
112 when experiencing or observing stroke symptoms. Relative 
improvement for both intent to call 112 and knowledge about 
the AKUT test was independent of sex and education level, but 
dependent on age as older individuals improved less. 
 
 The Swedish National Stroke Campaign was associated with a 
sustained increase in the proportion receiving recanalization 
therapy and with a small, but statistically significant, 
improvement in the proportion arriving at hospital within three 
hours. 
 
 Patients with symptomatic carotid stenosis undergoing CEA 
within 48 hours had a higher risk of death and/or any stroke 
within 30 days of the surgical procedure compared with those 
operated on later. 
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Future perspectives 
 
The inability to recognize stroke symptoms and call 112 is a central factor 
explaining patients delay in seeking urgent care for stroke. In order to reduce 
this delay, there are no other obvious ways to reach success than embarking 
on education efforts directed towards the general population. Stroke 
educational campaigns have a potential to increase stroke knowledge, reduce 
patients delay and increase the use of recanalization therapy.  
Consequently, the main important question is not if educational programs are 
effective or not, but how to design the most effective educational program. 
Future studies should therefore focus on finding the most effective methods 
to reach the entire population, including all relevant subpopulations within 
the target audience. Cost effectiveness analysis on this topic is also of 
paramount important to guide healthcare decision makers to allocate limited 
resources. 
One important challenge for future campaigns is how to optimize targeting 
of the elderly. Older individuals are an important target as they are more 
likely to both suffer and witness a stroke. In addition, older age is both 
independently associated with a longer time from stroke onset to admission 
at hospital (132) and with a significantly lower knowledge improvement 
during the Swedish National Stroke Campaign. 
One way forward may be to cooperate with specialists in pedagogics and 
communication which might increase both penetration and retention of an 
educational effort within the entire population.   
Repetition is perhaps the most intuitive principle of learning, which is why 
learning activities need to be repeated regularly. The effects of stroke 
educational campaigns decline post-intervention, both with respect to stroke 
knowledge and patient behavior, clarifying the importance of repetition. 
Therefore, future educational programs should be repeated regularly. The 
small additional follow-up campaign after the Swedish National Stroke 
Campaign may explain why the effects remained stable and did not decrease 
as we had expected.  
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With respect to urgent carotid surgery within the first two days after an 
ischemic event, it remains unclear whether the risk of complications 
outweighs the risk of recurrent stroke if carotid surgery is deferred. A clear 
answer may only be obtained by conducting a randomized controlled trial. 
However, such a study would require a large sample, which for several 
reasons may be very difficult to recruit, and therefore may not be feasible. In 
addition, there may be a high risk of crossovers, due to logistical issues, 
from the group with very early surgery intent to later surgery. In the absence 
of randomized trials, prospective data on large multicenter cohorts, 
investigating both the combined risk of recurrent stroke and procedural risk 
may be the second best but a more reasonable alternative. In such a study, 
patients should be included as soon as possible after an event. By urgently 
investigating all patients with TIA or minor stroke (with brain CT and CT 
angiography of the carotid arteries) and thereafter without delay recruit 
patients to a prospective study, selection bias would be reduced, thus 
enabling a study of the combined early risk of recurrent stroke as well as the 
periprocedural risk associated with carotid intervention. 
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